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General introduction 
Currently, DNA repair is an important issue. Inherited defects in DNA repair or the
processing of DNA damage can lead to genomic instability with eventual cell death.1-7
To date more than 125 genes directly involved in DNA repair have been identified.
These genes function in a diverse set of pathways.2-3
The mechanism of DNA repair is usually associated with oncological diseases, since
disturbances in DNA repair may lead to cancer. Relatively unknown is the fact that
DNA repair may also play a role in neurological diseases. There is increasing evidence
that DNA repair is involved in the development and maintenance of the nervous
system.8 In this thesis, we will take a closer look at this phenomenon.
Of the many types of DNA damage that occur within the cell, DNA double-strand
breaks (DSBs) are considered the most dangerous (Figure 1). DSBs can result from
exposure to exogeneous agents, such as ionizing radiation and chemotoxins, as well as
from endogeneous DNA-damaging agents and mechanical stress on the chromosomes.
They can also be produced during DNA replication. In addition DSBs are generated to
initiate recombination between homologous chromosomes during meiosis and occur as
intermediates in V(D)J (variable division joining) recombination, which is critical to the
formation of a diverse repertoire of T and B cell antigen receptors.3-7,9
Possible respons mechanisms to DNA double strand breaks are homologous
recombination (HR), a process whereby a homologous chromosome or sister chromatid
acts as a template to repair the break, and non-homologous endjoining (NHEJ), a
process that rejoins breaks with the use of little or no homology (Figure 2).3-7,10 In
addition to efficient DNA repair, correct activation of cell-cycle checkpoints upon
induction of DNA damage is of crucial importance for the maintenance of genomic
integrity. Checkpoints allow actively dividing cells to halt and repair damage before
segregation into daughter cells, or to induce apoptosis if the damage is irreparable
(Figure 1).9,11
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Figure 1.  DNA double-strand breaks. Causes, response mechanisms, and consequences in case of
inaccurate repair (adapted from van Gent DC, et al., 2001 8).
Diseases associated with genetic defect in DNA repair, the so-called DNA repair
disorders, include Bloom syndrome, xeroderma pigmentosa, Cockayne syndrome,
Fanconi anemia, ataxia telangiectasia, Nijmegen breakage syndrome, familial
adenomatous polyposis syndrome and Werner syndrome. These disorders show
overlapping clinical and cell biological features, but are genetically distinct.12,13
One of the DNA repair disorders that displays prominent neurologic deficits is ataxia
telangiectasia (AT). In this thesis we shall therefore focus on this disorder. AT is
characterized clinically by progressive cerebellar ataxia and oculocutaneous
telangiectasia.14-16
Futhermore we shall also give particular attention to Nijmegen breakage syndrome
(NBS). This disorder has long been considered as an AT variant, showing striking
similar features at the laboratory level. NBS also displays neurological dysfunction,
although to a much lesser extent. NBS is characterized clinically by microcephaly and
a typical facial appearance.17-20
Both AT and NBS exhibit chromosomal instability, immunodeficiency,
hypersensitivity to ionizing radiation, and a predisposition to cancer.
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Figure 2.  DSBs can be repaired by two repair mechanisms: homologous recombination and non-
homologous endjoining (adapted from Gennery et al., 2000 9).
Aim of the study
At the start of the present study in 1994, the clinical picture of AT was well known,
but the genetic defect still had to be elucidated. We detected four patients, three brothers
and an unrelated female case, with a variant phenotype lacking marked cerebellar
ataxia, but displaying increased alphafetoprotein concentration. The patients presented
with a resting tremor at young adult age and in the subsequent years developed a severe
spinal muscular atrophy. We were fascinated by these patients and wondered why they
were so different from classical AT patients. Time was on our side, as the identification
of the gene responsible for AT in 1995 and the development of new molecular genetic
techniques enabled us to search for explanations at the genetic level. 
The studies as described in part I of this thesis aim to characterize these variant AT
patients by comparing them with classical AT patients. We have focussed on the
neurological and genetic aspects. 
With regard to NBS, the clinical picture was less well known, although several reports
had reached the literature. 
The availability of the NBS registry in Nijmegen, containing the data of all NBS
patients in the world, and the unravelling of the gene defect in 1998, provided us with
an ideal opportunity to perform an extensive study of NBS.
The studies as described in part II of this thesis aim to establish the NBS syndrome
as a disease entity in all its aspects. Specific emphasis is laid on some neurological,
neuropathological, immunological and genetic features.
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Ataxia telangiectasia
Chapter 1
Introduction
Ataxia telangiectasia (AT) is defined as an autosomal recessive multisystem disorder
characterized by progressive cerebellar degeneration with onset in early childhood,
oculocutaneous telangiectasia, increased alphafetoprotein levels, immunodeficiency,
chromosomal instability, hypersensitivity to ionizing radiation, and predispostion to
cancer. The disease belongs to the group of the so-called DNA-repair disorders,
including Bloom syndrome, xeroderma pigmentosa, Nijmegen breakage syndrome,
Fanconi anaemia, and Werner syndrome. These disorders show overlapping clinical and
cell biological features, but are genetically heterogeneous.1-12
The gene responsible for AT, ATM (ATmutated), is located on chromosome 11q22-
23.4-6 The encoding protein, ATM, is involved in the processing of DNA damage and
maintenance of genome stability.9,12
AT has been observed in all races and in all regions of the world. Its incidence is
estimated at 1:40,000-80,000 births. Heterozygote carrier condition is found in about
0,5-1% of the general population.2,3,13 To date, in the Netherlands 27 families with one
or more affected member(s) with AT have been identified.14
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Historical background
Ataxia telangiectasia is often referred to as Louis-Bar syndrome based on the clinical
report by Denise Louis-Bar in 1941. She described a 9-year-old Belgian boy with
progressive cerebellar ataxia and extensive symmetrical cutaneous telangiectasia. The
author identified the syndrome as a previously undescribed entity belonging to the
phakomatoses.15 In fact the first clinical description of AT dates from 1926 by Syllaba
and Henner. They reported 3 adolescent Czech siblings with progressive
choreoathetosis and striking ocular telangiectasia. They considered the syndrome as a
variant of familial double athetosis.16 It was Martin who in 1964 recognized that the
syndrome was AT in which the athetotic component was predominant.17 AT was not
established as a disease entity until 1958 when it was first delineated
clinicopathologically, and given its name by Boder and Sedgwick. The presence of
primary cerebellar degeneration was noted, as well as the clearly heredofamilial nature
of the disease.18,19
After 1958 a rapid succession of reports on AT appeared in the literature during which
AT has been unfolded as a complex multisystem disease with various clinical and
cellbiological features. In 1988 Gatti found linkage of the syndrome to chromosome
11q22-23. In 1995 Savitsky et al. identified the defective gene responsible for AT: ATM
(ATmutated).1-6
-21-
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Figure 1. Cerebral MRI showing marked cerebellar atrophy in a 6-year-old patient with AT.
Clinical manifestations
Neurological features.
A hallmark of the disease is cerebellar ataxia, which usually is noticed at about 12 to
14 months of age, when the child first begins to walk. The ataxia is predominantely
truncal and becomes increasingly evident after the age of five. Most patients are
wheelchair-bound by the age of ten. Cerebral MRI then shows severe cerebellar atrophy
(Figure 1). Besides cerebellar ataxia, extrapyramidal features such as choreoathethosis
and dystonia are common. Myoclonia and resting tremor can also be present. Ocular
extrinsic movement disturbances are almost always present. These changes are complex
and sometimes difficult to characterize. They combine features of cerebellar and
extrapyramidal dysfunction. Electro-oculographic studies have confirmed difficulty in
initiating voluntary and involuntary saccades. In a later phase of the disease, usually
beyond adolescence, also neuromuscular features as polyneuropathy and neuronopathy
of anterior horn cells and dorsal root ganglia cells are frequently noted. Moreover
pyramidal tract signs often emerge.1-3,20,21 Pulmonary function often gradually shows
decline probably mainly due to muscle weakness (personal observation, unpublished
data). Mental retardation is not a characteristic feature of AT, although it has been
reported. Most patients have IQ scores within the average range or above.1-3 More
recently, it has been shown that AT patients show difficulties in cognitive processes,
which are associated with non-motor cerebellar function, such as thought modulation,
particularly judgement of explicit time intervals, and language.22
Non-neurological features
Oculocutaneous telangiectasia, is the second hallmark of the disease. It first appears
in most children between the ages of 3 and 5 years. Steadily progressive, it spreads in
a characteristic symmetrical pattern. It is first noticed in the angles of the eye and
spreads horizontally across the exposed portion of the bulbar conjunctivae, as fine,
bright red, symmetrical horizontal streaks (Figure 2). Telangiectasia can also be seen in
the eyelids, malar region, ears, cervix, antecubital and popliteal spaces, and less
frequently on the back of the hands, feet and in the soft and hard palate mucosa. The
telangiectasia are supposed to be progeric changes, because they resemble those found
in the old age. Hemorrhages rarely occur.1-3 Other progeric changes include atrophic
skin areas, keratosis, hyper- and hypopigmentation, and grey hair, which can be found
even in young children.
Most children with AT have retarded somatic growth. By adolescence, their height
and weight have typically dropped below the 3rd percentile. The stunting of growth is
not clearly understood. Gonadal dysfunction is common. Diabetes mellitus type II is
-22-
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often noted in early adulthood. Skeletal changes such as kyphosis, kyphoscoliosis,
talipes equines and talipes cavus have been reported.1-3
Sensitivity to infections
Infections are common in AT, particularly of the respiratory tract and are community
acquired. These occur in 50-80% of the patients. Opportunistic infections are rarely
seen.1-3 The severity of the infections does not always correlate with the severity of the
immunodeficiency.
-23-
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Figure 2. Telangiectasia of the bulbar conjunctiva in a 12-year-old patient with AT.
Hypersensivity to ionizing irradiation
AT patients are extreme radiosensitive. Severe radiation reactions, as radionecrosis of
the skin, have been reported in patients treated with conventional doses of radiation
therapy. Therefore ionizing irradiation is relatively contra-indicated in AT patients.1-3,23-
25 
Predispostion to cancer
Malignancies are frequently noted in AT. They occur in about 10-30% of the patients
and are predominately lymphoreticular neoplasms and leukaemia. Other neoplasms
reported are gastric adenocarcinoma, hepatocellular carcinoma, ovarian tumors, renal
cell carcinoma and cerebellar tumors (glioma, medulloblastoma).1-3,26,27
Laboratory features
Alphafetoprotein concentration
An elevation of serum alphafetoprotein level is one of the most constant laboratory
features in AT. It is found in more than 90% of the patients over the age of eight months.
Therefore it is an important diagnostic marker in patients over the age of eight months.
Values of 50-500 ng/ml are common (normal value: <10 ng/ml).1-3,28-30
Below eight months of age high alphafetoprotein levels are physiological and
particularly in the first months of life very high levels can be observed (Figure3).28-30
Immunological disturbances
Imunological disturbances are noted in about 60-80% of the AT patients and concern
both humoral and cellular immunity.
Concerning humoral immunity the most frequent findings are dysgamaglobulinaemia
with absent or low serum levels of IgA, IgE and/or IgG2 and IgG4. IgM is usually
normal or elevated. IgG may be decreased or normal.
Concerning cellular immunity the most frequent findings are decreased percentages of
CD3+ and CD4+ cells. The percentage of CD8+ cells may also be decreased. The
number of Natural killer cells usually is normal. In vitro lymphocyte stimulation tests
by mitogens phytohemagglutinin and pokeweed mitogen are generally depressed.1-3,31
-24-
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Figure 3. Alphafetoprotein (AFP) levels: normal values. The AFP levels are age dependent. They are
very high in the first months of life, and continually decline therafter until adult levels (< 10 ng/ml) are
attained at eight months of age. In AT values between 50 and 500 ng/ml are common (upper horizontal
bars). The star symbol represents the AFP concentration of the patient in the case report (adapted from Wu
et al.1981 29).
Cytogenetic features
Specific chromosomal aberrations typically occur primarily in T-lymphocytes in AT.
Cytogenetic studies performed on phytohemagglutinin (PHA)cultured T-lymphocytes
show chromosomal aberrations in almost all patients. Although there tends to be an
increased number of random chromosome breaks and rearrangements in AT, these
rearrangements occur preferentially in chromosomes 7 and 14 and are typically
inversions and translocations, with breakpoints corresponding to locations of T cell
receptor and immunoglobulin genes. Frequent rearrangements are inv (14) (q11q32),
inv (7) (p13q35), t(14;14) (q11;q32), t(7;14) (p13;q32), and t(7;14) (q35;q32) (Figure
4).1-3,32,33
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Figure 4. Chromosome 7 and 14 rearrangements in PHA- cultured lymphocytes in AT. The arrows
indicate the exchange points, which are frequently involved (adapted from Weemaes et al.,1984 33).
Radiation hypersensitivty and radioresistant DNA synthesis
Fibroblasts and lymphocytes cultured from AT patients have aberrant responses to
ionizing radiation with increased number of chromosomal aberrations. In colony
forming assays AT cells are about 5 times more sensitive to radiation or radiomimetic
drugs than normal cells.
AT cells also show radioresistant DNA synthesis (RDS). RDS is the inability to halt
or slow DNA synthesis after X or gamma irradiation. The inhibition of DNA synthesis
measured on fibroblasts obtained from skinbiopsy is two to three times less pronounced
than in normal cells (Figure 5).2,34,35
Pathology
General findings. External examination of the body will show the oculocutaneous
telangiectasia which is most common on the conjunctiva, ears and antecubital regions
of the arms. Short stature and diminished secondary sexual characteristics may be
present. Various features may be seen in the endocrine and reproductive glands of
young patients, including hypoplasia or dysplasia of the gonads. The thymus in patients
frequently shows atrophy or dysplasia. 
Diverse malignancies can be identified, particularly lymphomas and leukemia.
The lungs, frequently, reflect the effects of recurrent infections such as pleural effusions
and adhesions.1,2
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Figure 5.  Radioresistant DNA synthesis. in AT cells. The inhibition of DNA synthesis in cultured
fibroblasts after exposure to X-rays is clearly less pronounced in AT compared to normal controls.
Neuropathological findings. The neuropathology of AT is dynamic and
progressive.The early picture is that of a primary cerebellar cortical degeneration
followed, with advancing years, by diffuse pathology in brain, spinal cord, spinal
ganglia and peripheral nerves.
The most significant neuropathological changes are found in the cerebellum. The
cerebellum is usually grossly atrophic, the atrophy being most prominent throughout
the cerebellar vermis and rather less evident in its lobules. The atrophy of the cerebellar
cortex is reflected in marked thinning of the molecular layer, diminution in the number
of Purkinje cells, and thinning of the underlying granule cell layer. In patients with long
survival “empty” basket cells can be seen, suggesting degenerative change in time.
Brainstem abnormalities include neuroaxonal dystrophy with axonal swellings in the
nuclei gracilis and cuneatus. Degenerative changes in the basal ganglia encompass both
loss of pigmented neurons and loss of nerve cells with gliosis. Eosinophilic
intracytoplasmic inclusions, Lewy bodies, may be present. In the cerebral cortex
gliosis, neurofibrillary tangles, and gliovascular nodules can be noted. In addition
spongy degeneration can be found predominately around the blood vessels. The spinal
cord frequently shows loss of anterior horn cells, and degenerated neurites. The long
tracts, including the posterior columns, the spinocerebellar tracts, and the corticospinal
tracts, may show marked myelin loss. In spinal ganglia cells and Schwann cells of
peripheral nerves bizarre dystrophic changes and nucleomegaly are frequently noted.
Skeletal muscles often show denervation atrophy.1,2,36-38 
Molecular genetics
The ATM gene is very large. It extends over 150 kb genomic DNA and contains 66
exons. It produces a transcript of 12 kb and has an open reading frame of 9168
nucleotides.The ATM protein has a molecular mass of approximately 350 kDa and
posesses a carboxy-terminal kinase domain with distinct homology to the lipid kinase
phosphotidylinositol-3-kinase (Pl-3K) and the serine/threonine protein kinase DNA-
dependent protein kinase (DNA-PK). ATM is one of a growing family of high-
molecular-weight kinases that are conserved throughout eukaryotic evolution from
yeast to mammals.These proteins are involved in the procesing of DNA damage and
cell cycle controle. The ATM protein is located primarily in the nucleus, to lesser extent
also in the cytoplasm of normal human cells.5-9
A large number and a variety of mutations in the ATM gene have been described since
its identification. Most AT patients appear to be compound heterozygotes. Until now
more than 300 disease causing mutations have been reported worldwide. Most mutation
-28-
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lead to the truncation of the protein. The mutations are localized in the entire region of
the ATM gene, no evidence for the existence of hotspot mutations have been found.39-
42 A small number of mutations has a significant founder effect.43
In the Netherlands the mutation spectrum does not differ from that in the rest of the
world. In the 27 families with one or more AT patient 29 different mutations have been
identified.14 About 70% of the mutations are truncating mutations, including nonsense
mutations, deletions, and insertions leading to frameshift. The majority of the patients
appeared to be compound heterozygotes. Six patients appeared to be homozygotes. Five
of them had consanguineous parents and originated from Turkey, Tunisia and
Morocco.14
Pathogenesis
The specific pathogenesis of AT has still to be elucidated, although studies on the gene
product, ATM kinase, have provided enormous insight. ATM is a key protein in
maintaining genomic integrity in the face of extrinsic and intrinsic DNA damage. 
ATM is activated in response to DNA double strand breaks (DSBs) by an unknown
mechanism and phosphorylates downstream proteins involved in cell cycle checkpoint
control, DNA repair, and stress response. There are multiple ATM dependent pathways.
Major downstream targets of ATM include the tumor suppressor protein p53, the
checkpoint protein kinase Chk2, the breast cancer 1 gene product Brca1, and the
Nijmegen breakage syndrome 1 gene product NBS1 (nibrin), which forms a complex
with the DNA repair proteins human meiotic recombination11 (hMRE11) and human
RAD 50 (hRAD50).5-9,12 The proteins interact in a complex way. 
In normal cells DNA damage will halt or slow DNA synthesis facilitating DNA repair.
In cases of abundant damage, however, the choice of induction apoptosis will occur,
preventing survival of degenerated cells. ATM, thus plays an important role in the
choice between survival by means of DNA repair and termination by means of
apoptosis.5-9,12,50 Deficiency in ATM kinase disrupts these normal mechanisms and
then serious aberrations can be expected, particularly in tissues with high proliferative
capacity. In that light, immunodeficiency and predisposition for cancer in AT can be
understood.44-50 It is also comprehensible that postmitotic cells such as neurons in the
central nervous system are more vulnerable in case of dysfunctionating repair
mechanisms. It is still unclear, however, why specific Purkinje cells and anterior horn
cells are affected in AT. 
-29-
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Figure  6.  Central role of ATM in the signal transduction process induced by DNA double-strand breaks
(simplified scheme).Downstream targets of ATM include p53 and the hMRE11/hRAD50/NBS1 complex.
ATM can influence cell cycle progression facilitating DNA repair or make the choice of induction apoptosis
when the damage is beyond repair.
Abbreviations: ATM, ATM kinase; NBS1, Nijmegen breakage syndrome 1 gene product (also designated as
nibrin);hMRE11, human meiotic recombination 11; hRAD50, human RAD50 (adapted from van Gent et
al.50). 
AT heterozygotes, disease carriers
About 0.5-1.0% of the general population is disease carrier. AT carriers, heterozygotes
(for example the parents of the patients), do not display clinical features of AT, but
probably carry increased health risk. It has been shown that carriers of one mutant ATM
allele have an average life span of about 7-8 years shorter than that of normal
individuals.51
Although still controversial there is increasing evidence for an increased breastcancer
risk in female heterozygotes.The risk may be higher for certain mutations and therefore
the involvement of ATM gene mutations in breast cancer may be very significant in
particular families.52-54
Diagnosis
The clinical diagnosis of AT is unequivocal as the patient presents the 2 diagnostic
hallmarks of disease: early onset cerebellar ataxia and oculocutaneous telangiectasia.
As oculocutaneous telangiectasia often do not present before the age of 5, diagnosis in
the earliest stages may be difficult. The differential diagnosis of cerebellar ataxia is
broad. MRI scanning should be the investigation of first choice. In the case of cerebellar
atrophy AT should be considered. 
If AT is suspected, the alphafetoprotein level has to be determined, since an increased
level is almost pathognomonic for the disease. Strongly supportive of the diagnosis are
typical rearrangements of chromosome 7 and 14 and to lesser extent immunodeficiency
and hypersensivity to radiation. In most cases the diagnosis can be confirmed by DNA
studies, revealing ATM mutations. Prenatal diagnosis is possible by means of mutation
analysis on foetal DNA. 
Course and prognosis
The rate of progression of the disease and its severity vary considerably from one
patient to another. In general the course of AT is slowly progressive. Life span is often
reduced due to chronic infections and malignancies. Remarkably, despite the T cell
defects severe opportunistic infections rarely occur. The reason for this phenomenon is
not clearly understood. 
Death is common in the second and third decades. In the absence of infections and
malignancies, however, survival into the fourth to sixth decades has been reported.1-3 
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Therapy
There is no effective treatment for AT. All treatment is symptomatic. General
supportive measures as physical therapy and occupational therapy can improve quality
of life. Precocious treatment of infections is indicated. Human immunoglobulin can be
given in case of hypogammaglobulinaemia. 
Diagnostic procedures as X-rays and CT-scanning should be avoided. Avoidance of
undue exposure to sunlight is advocated. Treatment of malignancy may be difficult.
Ionizing radiation and radiomimetic drugs should be avoided or used at reduced dosage. 
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Table 1. Main characteristics of ataxia telangiectasia
clinical features
progressive cerebellar ataxia with onset in childhood
oculocutaneous telangiectasia
growth retardation
recurrent sinopulmonary infections
predisposition to cancer
laboratory features
increased alphafetoprotein level
reduced humoral and cellular immunity
radiation hypersensitivity
rearrangements of chromosomes 7 and 14
genetic characteristics
chromosome location: 11q23.1
gene defect: ATM (ATmutated)
protein: ATM (350 kDa), protein kinase
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Case report
The patient is the fifth child of healthy nonconsanguineous parents. Family history disclosed ataxia
telangiectasia in an older brother (the third child of the family) who had an IgA deficiency and died aged
14 of pulmonary disease. 
The boy was born in 1972 after 6,5 months of gestation. Pregnancy was complicated by mild fluxus from
4th month of gestation. Birth weight was 1320 g. The neonatal period was uneventful. Psychomotor
development was slightly delayed concerning motor skills. He was able to sit at 10 months of age and to
walk at 19 months of age. When he began to walk progressive balance difficulties were noted. At 2 years
old he was admitted to the hospital.
Examination revealed an alert, cooperative small boy. Weight 11,5 kg (P25), height 89 cm(P50), head
circumference 48cm (P25). On neurological examination a mild dysarthria was noted. Gait was fairly
ataxic, he was hardly able to walk without support. Moreover a slight intention tremor as well as a mild
choreathetosis in the hands was seen. Pyramidal tract signs were lacking. Cognition was normal.Results
of routine blood and CSF tests, lactic acid and amino-acids were all normal. Electromyography showed no
abnormalities. Pneumoencephalography showed dilatation of the 4th ventricle compatible with vermis
atrophy (CT/MRI were not yet available). 
Because of the family history the diagnosis ataxia telangiectasia was highly suspected. This diagnosis
was clinically established at age 3 when ocular telangiectasia was noted. In the consecutive years specific
AT studies were performed. Alphafoetoprotein level was markedly increased : 362,5 ng/ml (normal <
10ng/ml). Immunological studies showed decreased IgG2 and IgG4 levels: IgG2: 0,19 g/l (normal range
1,0-5,0 g/l), IgG4: 0,04 g/l (normal range 0,05-1,5 g/l) as well as a decreased percentage of CD4 cells:
15% (normal range 30%-50%). Cytogenetic studies in cultured peripheral lymphocytes revealed typical
rearrangements of 7 and 14: inv (7)(p13q35): 1/50 cells and t(7;14)(q35;q11): 1/50 cells. Moreover these
cells clearly showed more chromosomal aberrations after X-irradiation than did normal cells: relative
values: 46% versus 28%. Inhibition of DNA synthesis in peripheral lymphocytes was markedly disturbed.
Eventually, molecular genetic studies revealed ATM mutation: IVS40-2A>T (one mutant allele identified). 
During infancy the boy went through recurrent sinopulmonary infections, though severe infections never
occurred. At the age of 8 years amoxicillin profylaxis was given because of the immunodeficiency. Somatic
growth was retarded. At 8 years of age: height was 1.24 m (P10), at 10 years of age:1,23 m (3 cm below
P10), and at 16 years of age: height:1.50 m (17cm below P10). Neurologically he deteriorated gradually.
The ataxia became increasingly evident both in lower and upper extremities and he became wheelchair
bound in his early teenage years. Then also oculomotor dyspraxia and myoclonic jerks were noted.
Moreover pyramidal tract signs emerged and a kyphoscoliosis was seen. The cerebellar dysarthria
remained relatively mild. Mentally and socially he did well. He worked as a disc jockey for a while. Several
years later, in late adolescence striking distal atrophy and weakness were noted. EMG studies indicated
spinal musular atrophy and concommittant polyneuropathy. Quadriceps muscle biopsy was compatible
with spinal muscle atrophy. 
At 24 years of age diabetes mellitus type II was diagnosed necessitating oral antidiabetics. At 26 years
of age he was admitted to hospital because of dyspnoea and fever. No commonly acquired or opportunistic
infection could be detected. Treatment with broad spectrum antibiotics was unsuccesful. Eventually RS
pneumonia was considered and confirmed serologically. A spontaneous recovery was expected, but did not
occur. The clinical picture deteriorated and mechanical ventilation was necessary. Weaning from
ventilation was not possible. Respiratory muscle function was insufficient. His general condition gradually
worsened and a decision was made to stop further treatment. He died two months after admission. No
permission was given for autopsy.
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Abstract
Ataxia telangiectasia (AT) is an autosomal recessive disorder characterized by
cerebellar ataxia, telangiectasia, immunodeficiency, elevated alphafetoprotein levels,
chromosomal instability, predisposition to cancer, and radiation sensitivity. We report
the identification of a new, double missense mutation in the ataxia telangiectasia gene
(ATM) of a Dutch family. This homozygous mutation consists of two consecutive base
substitutions in exon 55: a T→G transversion at position 7875 of the ATM cDNA and a
G→C transversion at position 7876. These transversions were confirmed by
polymerase chain reaction/primer-induced restriction analysis with Celll. The double
base substitution results in an amino acid change of an aspartic acid to a glutamic acid
at codon 2625 and of an alanine to a proline at codon 2626 of the ATM protein. Both
amino acids are conserved between the ATM protein and its functional homolog, the
Atm gene product in the mouse. Furthermore, the Chou-Fasman and Robson
predictions both demonstrate a change in the secondary structure of the ATM protein
carrying the D2625E/A2626P mutation. These findings suggest that the double base
substitution in the ATM gene is a disease-causing mutation.
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Introduction
Ataxia telangiectasia (AT) is an autosomal recessive disorder characterized by
progressive cerebellar ataxia with onset in childhood, oculocutaneous telangiectasia,
immunodeficiency, chromosomal instability, and elevated levels of alphafetoprotein.
AT patients also have a predisposition to cancer, manifested primarily by lymphomas
and acute lymphocytic leukemia.1-3 Furthermore, AT cells are hypersensitive to ionizing
radiation and radiomimetic chemicals and are defective in cell-cycle checkpoints
activated by DNA damage.4,5 AT heterozygotes have a moderate cancer predisposition,
particularly to female breast cancer,6-8 and cultured cells from these individuals show
increased radiosensitivity.
Linkage analysis has shown that the gene responsible for AT is localized on
chromosome 11, at position q22-23.9 This gene, designated ATM (AT mutated), has
recently been cloned by Savitsky el al.10 using a positional cloning approach. The ATM
gene extends over 150 kb genomic DNA and contains 66 exons, which is, for a human
gene, one of the largest numbers of exons reported to date.11,12 It produces a transcript
of 12 kb and has an open reading frame (ORF) of 9168 nucleotides, which predicts a
large protein with a molecular mass of approximately 350 kDa.10,13 The ATM protein
is located primarily in the nucleus of normal human cells.14 It is a member of an
expanding family of large proteins with carboxy terminal regions, of ~350 amino acids,
showing a high similarity to the catalytic domain of phosphatidylinositol-3 kinases (Pl-
3 kinases). Members of this family include the Atm protein in the mouse, Tel1p and
Mec1p in budding yeast, rad3 in fission yeast, mei-41 in Drosophila, the catalytic
subunit of DNA-dependent protein kinase (DNA-PKCS) in mammals, the TOR1 and
TOR2 proteins in budding yeast and their mammalian homolog mTOR (RAFT, FRAP).
These proteins are involved in the processing of DNA damage, maintenance of genome
stability and control of cell-cycle progression. Mutations in the genes encoding these
proteins result in a variety of cellular phenotypes similar to these typical for AT, such
as radiosensitivity, chromosomal instability and defective cell-cycle checkpoints.10, 13,15
A large number and a wide variety of mutations in the ATM gene have been described
since the sequence of the coding region of this gene was first published.10,16-24 Most of
these mutations lead to truncation of the ATM protein. Mutations have been reported in
the entire region of the ATM gene and no evidence for the existence of hotspot
mutations has been found to date. Identification of the nature and the location of the
mutations present in the ATM gene is necessary to obtain a better understanding of the
function of the ATM protein and may provide insights into the molecular basis of the
disease. Furthermore, it is relatively simple to perform prenatal diagnostics when the
mutation(s) present in a family have been identified. To achieve these goals, we have
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investigated the presence of mutations in the Dutch population. In this report, we
describe a new, double missense mutation in the ATM gene, as found in two patients of
one Dutch family.
Materials and methods 
Patients 
Patients A and B are a brother and a sister who were both diagnosed with classical AT.
Their parents are said not to be consanguineous.
Patient A is a boy who died in 1981 at the age of l0 years. He had a progressive
cerebellar ataxia, ocular telangiectasia, an IgA deficiency, a T-cell defect. and
rearrangements of chromosomes 7 and 14 (ref. 25, patient 3). He died from a
lymphoma.
His sister, patient B, is an 18-year-old female. She has a progressive cerebellar ataxia,
ocular telangiectasia, elevated alphafetoprotein levels, and an immunodeficiency
(agammaglobulinemia and T-cell defect). At the cellular level, rearrangements of
chromosomes 7 and 14 and the occurrence of radioresistant DNA synthesis (RDS) were
observed.
Reverse transcription/polymerase chain reaction
A fibroblast cell line was established from patient A and a lymphoblast cell line was
established from patient B. Total RNA was extracted from these cell lines and was
reverse transcribed to cDNA for 1 h at 42° C. The reaction mixture of 40 µl contained
5 µg RNA as template, 200 U Superscript II reverse transcriptase (Life Technologies.
Breda, The Netherlands), the recommended buffer, 60 U RNAsin (Promega, Madison,
USA), 1.25 mM each dNTP, 10 mM DTT, 625 ng of an oligo(dT)l5 primer, and 625 ng
random primers (Promega). The reaction products were used as templates in the
polymerase chain reaction (PCR).
PCR and DNA sequencing
ATM cDNA was systematically amplified by PCR, in overlapping fragments of
approximately 500 bp. The primers used for the PCR amplification of the fragment that
contained the mutation were: forward primer, 5’-GGCATGATGAAGAGAGACGG-3’
(cDNA position 7504-7523); reverse primer, 5’-ATTCTCCTGTGTGGTCCACC-3
(cDNA position 8010-8029). The cDNA position refers to the ATM cDNA numbering,
with the first nucleotide of the ORF designated as +1 (Savitsky et al. 1995b; Genbank
accession no. U33841). PCR amplification was performed in a total volume of 100 µl,
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containing 1 µl of the reverse transcription products, 2 mM MgCl2, 0.2 mM each dNTP,
I U recombinant Taq polymerase (Life Technologies), the recommended buffer, and 40
pmol of each primer. An initial denaturation step of 3 min at 94° C was followed by 35
cycles of 1 min at 94° C, 1 min at 53° C, and 1 min at 72° C. Final extension was carried
out for 10 min at 72° C. The mutation was confirmed at the genomic DNA level by PCR
amplification of exon 55 of the ATM gene, by using the following primers: forward
primer,5’-AATAGGATCGAACAGA-GG-3’; reverse primer,5’-TTCTTCTTTAAAA-
AAAACATAC-3’. PCR amplification was performed in a total volume of 100 µl,
containing the same concentration of reactants as in the amplification of the cDNA
fragment, but with 100 ng genomic DNA; 30 cycles of 1 min at 94° C, 1 min at 50° C,
and l min at 72° C were preceded by an initial denaturation step of 3 min at 94° C and
were followed by a final extension step of 10 min at 72° C .
DNA sequencing was performed by direct sequencing of the PCR products, with the
ABI Prism Dye Terminator Cycle Sequencing Ready Reaction kit (PE Applied
Biosystems, Warrington. Great Britain) and the ABI Prism 377 DNA sequencer. The
PCR products were sequenced in both the forward and the reverse direction, by using
the same primers that were used in the amplification of the PCR products.
PCR/primer-induced restriction analysis
PCR/primer-induced restriction analysis (PCR-PIRA 26,27) was used as another
method to confirm the mutation and involved using cDNA as template. This technique
was also used as a quick method to investigate the presence or absence of this mutation
in four other AT patients belonging to three unrelated families. Furthermore, to
determine whether the mutation found is a disease-causing mutation, 90 control alleles
were screened with this technique. The control alleles were recruted from the local
University Hospital. The primers used for the amplification of the PCR-PIRA fragment
were: forward primer, 5’-GAAGTGTTGAGGACTTGCTGA-3’ (cDNA position 7853-
7874); reverse primer, 5’-ACCTCCATCATTTTCTTTTGGC-3’ (cDNA position 8402-
8423). The 3’-end of the forward primer is positioned at the nucleotide before the site
of the mutation; the first two nucleotides to be build in are either the wild-type
nucleotides (TG) or the mutant nucleotides (GC). Two mismatches were build into the
forward primer, thereby creating a restriction site in the mutant amplimer for the
restriction enzyme CelII at cDNA position 7871. The amplimer of both the wild type
and the mutant contained an additional restriction site for CelII at cDNA position 8073,
so that the activity of the enzyme could be checked. PCR-PIRA amplification was
performed in a total volume of 50 µl, containing 1 µl of the reverse transcription
products, 2.5 mM MgCl2, 0.2 mM each dNTP, 0.5 U recombinant Taq polymerase (Life
Technologies) and 20 pmol of each primer. An initial denaturation step of 3 min at 
-43-
A double missense mutation in the ATM gene of a Dutch family with ataxia telangiectasia
94° C was followed by 35 cycles of 1 min at 94° C, 1 min at 55° C, and 1 min at 72°
C. A final extension step was carried out for 10 min at 72° C. The amplification
products were digested with 3 U of Ce/II, and the digestion products were separated by
agarose gel electrophoresis on a 4% gel.
Results
Systematic screening of ATM cDNA by means of direct sequencing of PCR products
revealed a T→G transversion at position 7875 and a G→C transversion at position
7876. Both transversions were present in a homozygous state in both patients and were
confirmed at the genomic DNA level by direct sequencing of both strands of the
amplimer of exon 55 (Figure 1A1, 1A2). This mutation would lead to a substitution of
two amino acids: an aspartic acid to a glutamic acid at codon 2625 (D2625E) and an
alanine to a proline at codon 2626 (A2626P).The mutation was also confirmed at the
cDNA level by restriction enzyme analysis of the PCR-PIRA amplification products
with CelII. This enzyme cleaves the normal amplimer of 571 bp into two fragments of
221 bp and 350 bp, and the amplimer containing the mutation into three fragments of
19 bp, 202 bp, and 350 bp. In both patients, the normal-length digestion product of 221
bp was absent, again indicating that the mutation is homozygous (Figure I B). The same
mutation was also present, in a heterozygous state, in a patient of another unrelated
family of Dutch origin and appeared to be absent in the other three Dutch patients.
Screening of 90 control alleles revealed one individual who is heterozygous for this
mutation (data not shown).
The functional significance of the mutation was further analyzed by secondary
structure prediction according to Chou-Fasman 28 and Robson.29 Both methods showed
a conformational change of the ATM protein, induced by the two amino acid
substitutions. The Chou-Fasman prediction demonstrated that an α-helix is present
between codons 2615 and 2640 of the normal ATM protein; this is interrupted by a β-
sheet in the ATM protein containing the amino acid substitutions.
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Figure 1. Identification of the 7875T→G transversion and the 7876G→C transversion in the ATM gene
on genomic DNA (A) and on cDNA (B). A Sequence of the region of exon 55 surrounding the mutation. 
1 Wild Type. 2 Mutant. The two mutated bases are indicated by arrows . B Agarose (4%) gel electrophoresis
of the PCR-PIRA amplification products, before and after digestion with Cel/II. Lanes 1,2 Undigested PCR-
PIRA amplification product of patient A and control fibroblasts, respectively, lanes 3-6 PCR-PIRA
amplification products digested with Cell/II, lane 3 patient A, lane 4 patient B, lane 5 control fibroblasts,
lane 6 control lymphoblasts., M DNA molecular-size marker pUCl8 digested with Hae111 (587, 458, 434,
298, 267, 257, 174, 102,80, and 18 bp: the last three fragments are not present in this figure)
Discussion
In this study, a brother and a sister, both diagnosed as classical AT patients, were
investigated for mutations in the ATM gene. A large number of different mutations in
the ATM gene have been previously reported.10,16-24 Most mutations in the ATM gene
are unique to a single family. The majority of these mutations are (large) deletions and
insertions, splice site mutations, and nonsense mutations, all resulting in truncation of
the protein.
We report the detection of a new, double missense mutation in exon 55 of the ATM
gene: a T→G transversion at cDNA position 7875 and a G→C transversion at cDNA
position 7876. 
PCR-PIRA showed that this mutation was present in one of 90 control alleles. Although
we can not exclude that the mutation is a polymorphism it is remarkable that Swift et
al. reported that 1.4% of the general population (USA) is a carrier of a mutation in the
ATM gene.30 Both patients are homozygous for this mutation; this was confirmed at the
genomic DNA and cDNA levels (Figure 1A2, B, respectively). As far as we know, the
homozygous state of the mutation is not a result of consanguinity of the parents. This
mutation was also found in a heterozygous state, in another Dutch patient from an
unrelated family. The finding that this mutation is present in two Dutch families with
AT suggests a local founder effect (see also Gilad et al.18).
The double base substitution involves the codons of two amino acids. The aspartic
acid of codon 2625 changes to a glutamic acid and the alanine of codon 2626 changes
to a proline.
Although a large number and a wide variety of mutations have been identified in the
ATM gene of classical AT patients, missense mutations seem to be rare. This is in
contrast to patients with sporadic T-cell prolymphocytic leukemia (T-PLL), where
missense mutations in the ATM gene predominate.31 To our knowledge, seven missense
mutations have been described in classical AT patients to date. Combined missense
mutations in one allele have previously been reported in only one classical AT
patient. 22 The D2625E/A2626P mutation in our patients is located in the 5’ end of the
conserved PI-3 kinase domain of the ATM protein.10,13 Only one functional homolog of
the ATM protein has been described, namely the Atm gene product in the mouse (ref.
32; accession no. U43678). The aspartic acid of codon 2625 and the alanine of codon
2626 are conserved between the ATM protein and the Atm protein (data not shown).
Both the Chou-Fasman and Robson predictions demonstrate that the double amino
acid substitution induces a change in the secondary structure of the ATM protein. The
Chou-Fasman prediction shows that a long α-helix in the normal ATM protein is
interrupted by a β-sheet in the ATM protein containing the mutation. This is not
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surprising as proline is known to be a helix breaker. The change in secondary structure
is an indication that the activity of the protein might be reduced or even inhibited. The
conformational change of the mutated ATM protein, the nonpolymorphic nature of the
mutation, and the findings that the two substituted amino acids are located in the
conserved Pl-3 kinase domain of the ATM protein and that they are both conserved
between human and mouse suggest that the double base substitution in the ATM gene
is a disease-causing mutation.
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Ataxia telangiectasia
Chapter 3
Abstract
Two young adult brothers presented with a 5- to 6-Hz resting tremor of the upper
limbs. Although ataxia was not unequivocally present and ocular telangiectasia was
minimal, typical rearrangements of chromosomes 7 and 14, and increased α-fetoprotein
levels indicated the presence of ataxia telangiectasia (AT). Resting tremor as a
predominating symptom in AT is uncommon and to our knowledge has not been
described previously. 
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Introduction
Ataxia telangiectasia (AT) is an autosomal-recessive multisystem disorder
characterized by progressive cerebellar ataxia with onset in childhood, oculocutaneous
telangiectasia, high levels of α-fetoprotein, variable immunodeficiency, increased
chromosomal breakage (especially of chromosomes 7 and 14), hypersensitivity to
DNA-damaging agents, and failure to inhibit DNA synthesis after X-irradiation.1-6
Besides ataxia, neurological features such as choreoathetosis, oculomotor dyspraxia,
dysarthria, muscular hypotonia, diminished or absent deep reflexes, and flexor or
equivocal plantar responses also occur in AT.1-6 We describe two young adult brothers
who were diagnosed with AT but in whom cerebellar ataxia was not unequivocally
present. Their most striking symptom was a resting tremor. Immunological tests and
radiosensitivity were close to normal.
Case reports
Patient A had been admitted to the hospital for the first time at the age of 18 years
because of a slowly progressive tremor of unknown cause and ~2 years’ duration that
affected his whole body. His gait had always been fairly clumsy. On examination at that
time, a mild slurred tremulous dysarthria and a 5- to 6-Hz resting tremor of the arms
together with a 5- to 6-Hz postural tremor in the head and trunk were noted. The
amplitude of the resting tremor clearly diminished with action, but slight intention
tremor emerged during goal-directed movements of the hands. Cerebellar ataxia of the
limbs, hypokinesia, rigidity, and dystonia were absent. Eye movements were normal
without nystagmus or oculomotor apraxia. Apart from very low ankle tendon reflexes,
further neurological examination was unremarkable. Minimal ocular telangiectasia was
present.
Results of electromyography (EMG), nerve conduction studies (NCS), electroen-
cephalography, brain computed tomography, thyroid function, lysosomal enzymes,
lactic acid, and copper studies were all normal. Wechsler Adult Intelligence Scale IQ
was 92.
Anticholinergic therapy, levodopa, clonazepam, propanolol, primidone, alcohol, and
isoniazide in appropriate doses all failed to improve the tremor.
At 29 years of age, the patient started complaining of unsteadiness of gait. Examination
showed striking distal muscular atrophy, weakness of the lower extremities, and a
disturbance of tandem gait. Results of the heel-skin test were normal. Apart from the
abnormal findings in the legs, the clinical picture had not changed distinctly over the
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intervening years. Cerebrospinal fluid examination showed normal cell count and
normal protein, glucose. lactic acid, vitamin B12, folic acid and immunoglobulin A
(IgA) and IgM levels. The homovanillic acid level was lowered at 39 (normal range
100-400 nM). EMG of the legs showed abundant fasciculations, polyphasia, and
increased amplitude and duration of motor unit potentials. On NCS, the Hoffman
reflexes in the legs were absent; motor conduction velocity of the peroneal nerve was
36 (normal 45) m/s; and median nerve motor conduction was normal. Sural and median
nerve sensory action potentials were all within normal limits. Magnetic resonance
imaging (MRI) studies of the brain showed slight atrophy of the left caudate nucleus.
Because AT was suspected, specific studies directed at that diagnosis were performed
(Table l). The α-fetoprotein level appeared markedly increased. Immunoglobulin levels
were normal, except for a slightly increased IgM level. Concerning cellular immunity,
only CD3, cells were slightly decreased. The in vitro response of peripheral blood
lymphocytes was moderately depressed to the mitogen phytohemagglutinin and was
normal to pokeweed mitogen. Cytogenetic studies in cultured peripheral lymphocytes
showed rearrangements of chromosome 7. These cells showed slightly more
chromosomal aberrations after X-irradiation than did normal cells. Inhibition of DNA
synthesis in peripheral lymphocytes after X-irradiation was normal.
Patient B, the brother of the first patient, was 28 years of age at first examination. He
had had a slight tremor in both arms since the age of 26 years. On examination, a mild
mental retardation was detected. Minimal ocular telangiectasia and mild dysarthria was
noted. Furthermore, a resting tremor existed that prevailed over a mild intention tremor
in both arms, together with a less pronounced postural tremor of the head and trunk.
Gait was normal, as were eye movements, with no nystagmus or oculomotor apraxia.
Signs of cerebellar ataxia, hypokinesia, rigidity, or dystonia were absent. Further
neurological examination was unremarkable. The clinical presentation showed a
striking resemblance to that of his brother, although less pronounced.
EMG of the legs showed some fasciculations and increased duration of motor unit
potentials. On NCS the amplitudes of the Hoffmann reflexes in the legs were reduced.
Motor conduction velocity of the peroneal and median nerves and sural and median
nerve sensory action potentials were all within normal limits. MRI of the brain showed
only slight atrophy of the vermis superior.
The α-fetoprotein level was markedly increased. Immunological studies showed no
abnormalities, with the exception of a slight decrease of CD2+, CD3+, and CD4+ cells.
Cytogenetic studies in cultured peripheral lymphocytes showed rearrangements of
chromosomes 7 and 14. These cells showed slightly more chromosomal aberrations
after X-irradiation than did normal cells. Inhibition of DNA synthesis in peripheral
lymphocytes after X-irradiation was slightly disturbed but less so than in classical AT.
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Results of laboratory studies mentioned above are listed in Table 1.
Discussion
As a rule, ataxia in AT presents in infancy or early childhood, and most patients
become wheelchair bound before adolescence. Our patients did not show this classical
syndrome. They showed only minor ocular telangiectasia and minor cerebellar ataxia.
Results of immunological tests were nearly normal, and radiographic hypersensitivity
was intermediate (Table 1). Nevertheless, the typical rearrangements of chromosomes
7 and/or 14 and the increased α-fetoprotein levels indicate that these patients do indeed
have AT.1-4,7,8 Both patients presented in young adult life with predominant resting
tremor and slight intention tremor in the upper limbs and a postural tremor of head and
trunk. Although patient A after about 13 years started complaining of problems with
gait, this was thought to be mainly due to spinal muscular atrophy because of the
presence of leg weakness and because the heel-skin test was normal. However, the
disturbance of tandem gait indicated that cerebellar locomotor ataxia was also present.
Our patients did not show other symptoms of cerebellar involvement, except for the
mild dysarthria and slight intention tremor, both symptoms being compatible with
cerebellar dysfunction.9 Furthermore, MRI did not show cerebellar atrophy in patient
A, and MRI abnormalities in patient B were minimal, whereas cerebellar atrophy is
normally present in AT.1,2 In patient A the spinal fluid HVA level was lowered and MRI
showed slight caudate atrophy. Both findings are compatible with extrapyramidal
pathology as the most probable cause of the predominating resting tremor of the hands.
The clinical syndrome of resting tremor without definite ataxia and only minor
disturbances of immunological tests and radiosensitivity are unusual in AT. Until now,
many variants of AT have been described, but to our knowledge ataxia has been a
constant finding in all cases.10-14
Our patients show that in cases of resting tremor accompanied by ocular
telangiectasia, AT should be considered, even when ataxia is not unequivocally present. 
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Videotape segments accompany this article
Legend to videotape
Patient A is a 29-year-old man who has been experiencing a resting tremor of the arms and a postural
tremor of head and trunk for 13 years. The patient’s gait has become unsteady in the past year. During goal-
directed movements, a slight intention tremor is seen; however, striking ataxia is not seen. When the patient
is standing still, a 5- to 6-Hz resting tremor in the arms and a postural tremor in the head and trunk are seen.
The pegboard test demonstrates that there is neither a tremor nor ataxia in the hand in action. The hand
leaning on the table is also free of tremor at that moment. However, when the patient is lying down and
completely at rest, a tremor in the hands is seen, indicating that the tremor is a resting tremor. Examination
of the eyes shows minimal ocular telangiectasia.
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Ataxia telangiectasia
Chapter 4
Abstract 
We describe 4 adult onset ataxia telangiectasia (AT) patients belonging to two
families lacking pronounced cerebellar ataxia but displaying severe spinal muscular
atrophy. The diagnosis of AT was proven by genetic studies showing ATM mutations on
both alleles and a reduced level of ATM protein. The ATM activity, as measured by the
phosphorylation of p53, was close to normal, indicating that the p53 response is not the
only factor in preventing neural damage in anterior horn cells in AT. 
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Introduction
Ataxia telangiectasia (AT) is an autosomal recessive multisystem disorder
characterized by progressive cerebellar ataxia with onset in childhood, oculocutaneous
telangiectasia, high levels of serum alphafetoprotein, immunodeficiency, T lymphocyte
chromosomal instability (especially of chromosomes 7 and 14), radiation
hypersensitivity and cancer predisposition.1-5 The gene responsible for AT, ATM (AT
mutated) is located on chromosome 11q22-23. The protein, defective in AT, ATM, is
central to the signal transduction process induced by DNA double-strand breaks. ATM
orchestrates the response to this DNA lesion by phosphorylating numerous substrates,
such as p53, chk2, c-Abl, BRCA1,and NBS1, which are involved in cell cycle
checkpoint regulation, DNA repair and apoptosis.6-13 One of the major downstream
proteins reported to be crucial in mediating ionizing radiation-induced cell death in the
cerebellum and central nervous system is p53.8-11,14
Studies concerning neuromuscular features in AT are relatively sparse. Axonal
polyneuropathy and/or neuronopathy of anterior horn motoneurons as well as dorsal
root ganglia cells have been reported. These features usually become more evident with
age and are mainly seen late in the second decade of life, when most AT patients have
already been wheelchair bound for many years because of severe cerebellar ataxia.15-20
We present 4 adult onset AT patients with prominent spinal muscular atrophy with only
slight cerebellar ataxia. We correlate clinical, electrophysiological and pathological
findings with the results of ATM immunoprecipitation and p53 phosphorylation.
Methods
Subjects. The patients investigated were 3 brothers (A1, A2, A3) and a single
unrelated female case (B) in a second family with ages ranging from 38 to 43 years.
They all experienced progressive unsteadiness of gait during the past decade. They
presented with resting tremor at young adult age, an aspect that has been previously
described in patient A1 and A2.21 Increased alphafetoprotein levels and typical
rearrangements of chromosomes 7 and 14 were present, moreover linkage analysis
performed in the family of patients A showed linkage to chromosome 11.22
All patients underwent extensive clinical and laboratory evaluation, including
electrophysiological testing, muscle biopsy, cerebral MRI scanning and molecular
genetic studies. 
Electrophysiological studies. Motor nerve conduction velocities (MCV) of peroneal
nerve, and tibial nerve and their compound muscle action potentials (CMAP) were
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measured, as well as sensory nerve velocity (SNV) and sensory compound nerve action
potential (SNAP) of sural nerve and/or median nerve, and Hoffman reflexes (soleus).
Needle electromyography was performed in quadriceps muscle and anterior tibial
muscle.
Muscle biopsy. Biopsy was performed from the quadriceps muscle. The specimens
were obtained with a Bergström needle, quickly frozen and cut for light microscopic
investigations. The sections were stained with haematoxylin/phloxine (H-phl) and for
ATP-ase, succinate dehydrogenase (SDH), cytochrome oxidase (COX) and acid
phosphatase (AcP) activity.
Furthermore the muscle specimens were prepared for ultrastructural examination.
Molecular genetic studies. Genomic DNA was isolated according to established
procedures. ATM mutation detection was performed using Denaturing Gradient Gel
electrophoresis (DGGE). For each patient each ATM exon was amplified separately
with PCR (primers were designed using the Ingeny melt analysis software, primer
sequences are available upon request) and analysed on polyacrylamide 20-55%
ureum/formamide gradient gel and run O/N, 120 V at 59° C. All aberrations were
confirmed with genomic sequence analysis. Sequencing products were analysed with
the ABI 3700 automated sequencing apparatus and Vector NTI Suite 7 software. 
ATM Immunoprecipitation. Approximately 4x107 lymphoblastoid cell line (LCL)
cells were lysed at 4° C for 30 minutes in TGN lysis buffer (50 mM Tris/HCl (pH 7.5),
150 mM NaCl, 1% (v/v) Tween-20, 0.2% (v/v) Nonidet P-40, 1 mM
phenylmethylsulfonyl fluoride, 1 mM sodiumfluoride, 1 mM sodium orthovanadate, 10
mg/ml aprotinin, 5 mg/ml leupeptin, 2 mg/ml pepstatin A). Cellular debris was pelleted
for 15 minutes at 4° C (13,000 rpm). 1.5 mg of whole cell extract was pre-cleared with
30 mg of Protein A beads (Sigma) pre-washed three times in TGN buffer for 1 hour at
4° C on a rotator. Cleared lysates were incubated with 10 mg Ab-3 anti-ATM antibody
(Oncogene Science) for 2 hours at 4° C on a rotator. Immune complexes were
precipitated for 1 hour by rotating at 4° C with 30 mg of Protein A beads pre-washed
three times in TGN buffer. Bead-bound immunoprecipitates were washed three times in
TGN buffer, boiled in SDS sample buffer and loaded on an SDS 6% polyacrylamide
gel. Proteins were transferred to nitrocellulose and immunoblots were performed using
ATM (FP8r) antiserum.10
p53 phosphoserine 15 analysis. Exponentially growing LCL cells (~3x106 per time
point) were irradiated with 5Gy of 60Co gamma rays (~1Gy/min) and subsequently
incubated at 37° C. Cells were harvested at the time points indicated and washed three
times in ice-cold phosphate buffered saline. Cells were then sonicated in TGN buffer
(see above) and cellular debris removed by centrifugation. 20 mg of whole cell extract
from each time point was loaded on to an SDS 10% polyacrylamide gel, the proteins
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transferred to nitrocellulose and immunoblots performed using p53 phosphoserine 15
antiserum (New England Biolabs).10
Results
Clinical and electrophysiological studies
The clinical picture of patients A1, A2 and A3 and the unrelated patient B showed
essentially similar findings (Table 1). Striking distal muscular atrophy and particularly
distal weakness of the lower extremities were noted. The tandem gait was disturbed, but
the heel-skin test was normal. Sensory modalities were normal. Ankle jerks were
lowered or absent. Furthermore a mild dysarthria and a severe resting tremor were
noted. During goal-directed movements a slight intention tremor was seen. Eye
movements were normal without nystagmus. Ocular telangiectasia was minimal. 
Immunological studies showed only slight decreases of T cell markers.
Immunoglobulin serum levels were normal or close to normal (data not shown).
Radiation hypersensitivity was minimal as shown by analysis of irradiated lymphocyte
chromosomes and also by radioresistant DNA synthesis (data not shown). 
Cerebral MRI revealed no cerebellar abnormalities in patient A1, and B, whereas only
slight atrophy of the vermis superior of the cerebellum was noted in patient A2 (data of
patient A3 not available). In all patients nerve conduction studies showed normal or
borderline delayed MCVs with markedly decreased CMAPs (Table 2). Sensory studies
were within normal limits. On needle electromyography spontaneous activity including
fibrillation potentials, positive sharp waves and fasciculations were seen both in
proximal and distal muscles. Abnormal myograms were seen in all patients. Giant
potentials and reduced recruitment of motor unit action potentials were noted. In
patients A1 and A2 previous EMGs were available showing progression of
abnormalities in time. An EMG performed in patient A1 at age 18 was normal. 
Histological findings (quadriceps muscle)
In all patients neurogenic changes were found by light microscopy (Table 2, Figure
1). Atrophic fibers with pyknotic nuclei, type grouping and extreme fiber variability
were seen. Using electronmicroscopy, at the ultrastructural level no additional relevant
abnormalities as compared to light microscopy were found.
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Table 1. Clinical and laboratory data of the four adult onset AT patients compared
with classical AT patient at adult age
Classical AT Adult onset AT patients 
patient at
adult age Al A2 A3 B
Sex M M M F
Age 38 37 43 42
DNA mutations 7622C→T 7622C→T 7622C→T IVS21-1G→A
3136C→T 3136C→T 3136C→T 8147T→C
Age of onset unsteadiness 
of gait (yrs) < 2 29 30 37 32
Age wheelchairbound (yrs) since still still still still 
age 10 ambulant ambulant ambulant ambulant
Clinical features
Neuromuscular findings (legs) 
proximal/distal
weakness ± / ++ + / +++ + / +++ + / +++ ± / ++
atrophy - / ++ - / +++ - / +++ -/ +++ - / ++
sensory deficit - / + - /- - / - - / - - / -
diminished deep reflexes no / yes no / yes no / yes no / yes no / yes
Cerebellar ataxia +++ ± ± ± ±
Ocular telangiectasia +++ + + + +
Resting tremor ± +++ +++ +++ +++
Laboratory features
Increased alphafetoprotein level present present present present present
Immunodeficiency +++ ± ± ± ±
Rearrangements 
chromosomes 7 and 14 present present present present present 
Percentages of cells with 
chromosomal aberrations 
after X-irradiation 70-90% 24 26 NA 22
Radiation resistant DNA synthesis disturbed normal intermediate NA NA
Cerebellar atrophy on MRI +++ - + NA -
M = male; F = female;
NA = data not available; - = absent; ± = borderline; + = slight; ++ = moderate; +++ = severe
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Table 2. Electrophysiologic and histologic findings
Al A2 A3 B
Normal
values 
CONDUCTION STUDIES
Motor conduction velocities (m/s)
Peroneal nerve 43 - 56 36 34 41 49
Tibial nerve 42 - 57 34 43 40 47
Sensory conduction velocity (m/s)
Sural nerve 42 - 58 NA 44 NA 48 
Compound muscle action potential (mV)
Peroneal nerve 3.1 - 11 0,6 0,2 0,5 1,1
Tibial nerve 4.5 - 22 0,6 0,9 1,3 
Compound sensory nerve 
action potential (µV)
Sural nerve 9 - 37 10 18 21 10
Median nerve 12 - 78 18 33 20 NA
H-reflex latency Soleus (ms) 24 - 33 absent absent 34 absent 
MYOGRAM
Quadriceps muscle/Anterior tibial muscle
Spontaneous activity - +/++ +/+ +/+ +/+ 
Motor unit action potentials
prolonged duration - +/+ +/+ +/+ +/+
large amplitudes - ++/++ +/+ +/++ ++/+
reduced interference pattern - +/+ +/+ ++/++ +/+ 
MUSCLE BIOPSY (quadriceps)
% type 1 fibers 36 - 51 95 55 30 62
% fibers with intemal nuclei 0 - 3 3 3 7 6
type grouping - + ++ ++ ++
atrophic fibers with pyknotic nuclei - + ++ ++ +
% of area with fat cells 0 10 2 30 5
small angular fibers - - + ++ +
lobulated fibers - ++ - + +
muscle fiber diameters
variability - ++ +++ +++ +++
atrophy - + ++ +++ ++
hypertrophy - ++ ++ +++ ++ 
NA = data not available, - = absent, + = slight, ++ = moderate, +++ = severe
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Figure 1A,B. Quadriceps muscle biopsy from patient A2 showing typegrouping (Fig. A) of type I
(black) and type II (white) fibers. Figure B illustrates some atrophic fibers with pyknotic nuclei (arrows).
ATPase stain after preincubation at pH 4.3 and H-Phl stain (B). Length of white and black bar: 5 µm
Molecular genetic studies 
Molecular genetic studies showed two mutations both in patients A and patient B. In
patients A, the three brothers, two missense mutations were found: 7622 T→G (exon
53) and 3136 C→T (exon 23). The 3136 C→T mutation was also present in their
healthy mother. In patient B a splice-site mutation, IVS21-1G→A (exon 22), and a
missense mutation, 8147T→C (exon 57) were identified. Her healthy daughter
harboured the IVS21-1G→A mutation. 
Immunoprecipitation
Immunoprecipitation studies showed that ATM protein could be immunoprecipitated
readily from normal cells, but there was complete absence of ATM protein
immunoprecipitated from lines from classical AT patients. In comparison, low levels of
ATM protein could be immunoprecipitated from cells from patients A1, A2 and B
(Figure 2).
p53 serine 15 phosphorylation as a measure of ATM kinase activity 
ATM is a serine/threonine protein kinase, and phosphorylates many downstream
proteins including p53. Following DNA damage, p53 becomes phosphorylated at
several sites. Phosphorylation of serine 15 of p53 is required for its transcriptional
activity and is ATM-dependent immediately following DNA damage.9,10,13 To test the
kinase activity of the residual ATM protein in the cell lines derived from patients A1,
A2 and B we examined their ability to phosphorylate p53 ser15 following exposure of
the cells to 5Gy of ionising radiation. Serine 15 phosphorylation occurred rapidly
within 1 hour and increased to a peak at 4-8 hours in normal LCL cells (Figure 3). In
contrast, classical AT LCL cells showed delayed phosphorylation kinetics with a much
lower level of serine 15 phosphorylation still increasing 8 hours after irradiation. Cell
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Figure 2.  ATM imunoprecipitation from LCL whole cell lysates of normal control, classical AT patient,
and patients A1, A2 and B.
extracts from A1, A2 and B, however, showed normal p53 serine 15 phosphorylation
kinetics, again rapidly phosphorylating serine 15 within 1 hour and reaching maximum
levels after 4-8 hours. The overall amount of p53 serine 15 phosphorylation appeared
to be slightly lower than normal but considerably more than the classical AT. It can be
concluded that these cell lines express low levels of mutant ATM protein that retain
sufficient kinase activity to phosphorylate serine 15 of p53 to near normal levels 
(Figure 3). 
Discussion
The patients are genetically confirmed AT patients showing mutations in the ATM
gene on both alleles and reduced ATM protein levels. They presented with a resting
tremor at young adult age and in the subsequent years developed a severe
predominately distal spinal muscular atrophy of the lower extremities. 
The diagnosis spinal muscular atrophy was based on the following findings: (a)
atrophy and weakness, (b) normal to borderline delayed motor conduction velocities
with markedly decreased compound muscle action potentials, (c) denervation activity
in both quadriceps and anterior tibial muscle, and (d) neurogenic changes with type
grouping in muscle biopsy. The onset of spinal muscular atrophy was at about 30 years
of age (range 29-37). Signs of concommittant polyneuropathy and/or neuronopathy of
dorsal root ganglia cells were lacking. None of the patients had neuromuscular
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Figure 3.  p53 induction time-course following 5Gy of γ-irradiation for normal control, classical AT
patient, and patients A1, A2 and B.
complaints at earlier age. An EMG performed in patient 1 at age 18 did not show any
abnormality, ruling out subclinical manifestations at that time
Striking are the very mild clinical signs of cerebellar ataxia, correlating with the MRI
findings showing a normal aspect of the cerebellum in patient A1 and patient B and only
slight atrophy of the vermis superior in patient A2. Striking also are the minimal ocular
telangiectasia, and the results of immunological tests and radiosensitivity which
appeared close to normal.
The finding of severe spinal muscular atrophy in the absence of marked cerebellar
ataxia is very unusual in AT. In classical AT cerebellar ataxia is a hallmark of the disease
and is first noted at about 12 to 14 months of age. The ataxia becomes increasingly
evident after age 5 and most patients become wheelchair bound by the age of ten.
Cerebellar MRI, then shows severe cerebellar atrophy. Spinal muscular atrophy
develops in a later phase of the disease, usually in the third decade of life, and is
superimposed on the cerebellar ataxia. At that time involvement of peripheral nerves
and dorsal root ganglia cells is also often noted. Like the cerebellar ataxia the
neuromuscular features show progression in time.2-4,19 In our patients the spinal
muscular atrophy was not essentially different from the spinal muscular atrophy found
in classical AT, although its onset was slightly later. The absence of concomitant
polyneuropathy is remarkable. The finding of nearly normal laboratory results for
immunity and radiosensitivity is also unusual. In classical AT moderate to severe
immunodeficiency as well as marked radiosensitivity is common.1,3
The presence of these variant, less severe phenotypes as observed in our patients
gives insight into the role of the ATM protein in the various structures of the nervous
system as cerebellum and spinal motor neurons. Obviously, in our patients, the ATM
kinase activity as measured by the p53 response, is sufficient for maintaining cerebellar
functions as well as for immunological and cell biological features, but is insufficient
for maintaining anterior horn function in the spinal cord. In the patients, a still
detectable amount of ATM protein was found in accordance with previous publications
on other AT patients with mild clinical phenotypes and some basal level/activity of
ATM protein. In contrast to the presented patients, all those reported variants, however,
showed unequivocally ataxia. The underlying ATM genotypes were either homozygous
for mutations expected to produce mild phenotypes or compound heterozygotes for a
mild and severe mutation.10,23-28 In our patients, being compound heterozygotes, we
identified in total three missense mutations and one splice-site mutation. Particularly
missense mutations have been associated with residual ATM activity.10,27,28 The two
missense mutations identified in patients A have not been reported previously in the
ATM mutation database (http://www.benaroyaresearch.org), neither as cancer mutation
nor as common polymorphism. Although the patients show reduced protein levels, the
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consequence of these particular mutations on protein level cannot be predicted solely
from their sequence position. The two mutations identified in patient B are likely to be
genuine disease causing mutations which can explain the reduced protein level in this
patient. The splice-site mutation IVS21-1G→A is localized at the highly conserved -1
position (100% conserved nucliotide G) of the 3’ splice acceptor site of exon 22, and
therefore most likely interferes with normal splicing machinery, resulting in shortened
and or truncated ATM protein. The second mutation is the missense mutation
8147T→C, previously identified as resulting in kinase inactivation and therefore
interfering with normal ATM function.29
Although neuroprotective, the specific molecular details of ATM function in the
nervous system are still unclear. There are multiple ATM dependent pathways.12,30 As
shown by animal studies ATM is involved in early Purkinje cell neurogenesis, and is
required for eliminating damaged postmitotic cells. After DNA damage induced by
ionizing irradiation ATM initiates a p53-dependent apoptotic cascade in differentiating
neural cells, thus preventing dysfunction of these cells in later life. So, p53 seems to
play an important role in cerebellar development.7,8,31-36 The finding of a nearly normal
p53 response in our patients is in concordance with the only mild cerebellar ataxia. 
At present no studies are available on ATM expression and/or p53 response in the
anterior horn cells. There is only one report on p53 in an other anterior horn cell
disorder, namely spinal muscular atrophy type I (Werdnig Hoffman disease). The
mutated SMN1 gene product and the SMN2 transcript, SMN∆7 (lacking exon 7), fail to
associate normally with p53, resulting in p53 accumulation and activation of p53-
dependent apoptotic pathways. The more this association is disturbed the more severe
appears the disease.37 These data suggest that for maintaining anterior horn function
also a proper p53 response is required. As the p53 response was nearly normal in our
patients with severe spinal muscular atrophy it can be concluded that in AT concerning
the anterior horn cells p53 apparently is not the only critical factor. Other genetic
modifying or enviromental factors must play a role.
In conclusion, AT may present clinically with various phenotypes. Usually, cerebellar
ataxia is a prominent feature, however less severe phenotypes with spinal muscular
atrophy lacking marked cerebellar ataxia may be observed correlating with a still
detectable ATM protein level and a near normal p53 activity. 
AT should be considered in patients with spinal muscular atrophy of undertermined
cause. We advocate to determine alphafetoprotein levels in these patients.
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Abstract
Background-Nijmegen breakage syndrome (NBS) is a rare autosomal recessive
disorder. NBS1, the gene defective in NBS, is located on chromosome 8q21 and has
recently been cloned. The gene product, nibrin, is a novel protein, which is member of
the hMre11/hRad50 protein complex, suggesting that the gene is involved in DNA
double-strand break repair. 
Aims-To study the clinical and laboratory features of NBS as well as the genotype-
phenotype relation.
Methods-fifty-five patients with NBS, included in the NBS registry in Nijmegen
were evaluated. The majority of the patients were of Eastern European ancestry. Most
of them had shown a truncating 5 bp deletion 657-661 delACAAA. Four further
truncating mutations have been identified in patients with other distinct haplotypes.
Results and conclusions-Essential features found in NBS were microcephaly,
usually without severe retardation, typical facial appearance, immunodeficiency,
chromosomal instability, X-ray hypersensitivity and predisposition to malignancy. In
40% of the patients cancer was noted before the age of 21 years. Important additional
features were skin abnormalities, particularly cafe au lait spots and vitiligo, and
congenital malformations, particularly clinodactyly and syndactyly.
Congenital malformations, immunodeficiency, radiation hypersensitivity, and cancer
predispostion were comprehensible in case of dysfunctioning of DNA repair
mechanisms.
No specific genotype-phenotype relation could be found. Patients with the same
genotype may show different phenotypes and patients with different genotypes may
express the same phenotype. Specific mutations did not lead to specific clinical
features.
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Introduction
Nijmegen breakage syndrome (NBS) is a rare autosomal recessive condition, which
belongs to the so-called DNA repair disorders, which also include Bloom syndrome,
xeroderma pigmentosa, Fanconi anemia and ataxia telangiectasia. These disorders show
overlapping clinical and cell-biological features, but are genetically heterogeneous.1-29
Spontaneous chromosomal instability, predisposition to cancer and immunodeficiency
are characteristic features of NBS, Bloom syndrome and ataxia telangiectasia.1-29
The gene responsible for NBS, NBS1, is located on chromosome 8q21 and has
recently been identified.26,27 The encoding protein has been named nibrin. The domains
found in nibrin and the NBS phenotype suggest that NBS is caused by defective
responses to DNA double-strand breaks.27,28
In this report we provide an extended follow up of the first recognised NBS patient
described in 1981 and evaluate the clinical and laboratory features of 55 NBS patients
included in our NBS registry in Nijmegen. 
Case report
This boy (Figure 1) is the sixth child of consanguineous healthy parents (second
cousins). He was born in 1969 after a pregnancy of 38 weeks duration. Pregnancy was
complicated by pyelonephritis at 24 weeks. Birth weight was 2500 g (P10) (data
concerning length and head circumference at birth not available). The neonatal period
was normal. When he was 6 weeks old his head circumference was 33 cm (< P3).
Development of language skills was delayed. During infancy he suffered from recurrent
upper respiratory tract infections, chickenpox and measles. Special education was
necessary because of learning difficulties and hyperactivity. We examined him aged 9,
when we noted a small microcephalic boy with head circumference 45 cm (< P3),
height 124 cm (< P3), and weight 21 kg (< P3). He had a typical face with a receding
forehead, prominent midface with long nose, and a receding mandible. Sun sensitive
erythema of the face and many freckles were noted as well as café-au-lait spots and
patches of vitiligo. TIQ was 67. Neurological examination was otherwise
unremarkable. EEG revealed no abnormalities. Routine blood tests were normal, as
were endocrinological studies. Immunological studies showed IgA and IgE deficiency
with normal IgG and IgM (IgA < 0.05 g/l, IgE < 1 IU/ml, IgG 11.30 g/l, IgM 0.69 g/l);
cellular immunity was normal. Cytogenetic studies revealed multiple rearrangements of
chromosomes 7 and 14. We proposed a provisional name of Nijmegen Breakage
Syndrome (NBS).1
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At 13 years of age mild thoracolumbar scoliosis was noted. At 14 years of age he
experienced repeated skin infections and suffered a severe bronchopneumonia. Head
circumference remained below P3 (Figure 2). At the age of 17, repeat immunological
studies showed undetectable serum IgA and serum IgE concentrations and disturbances
in synthesis of specific antibodies as well as some disturbances in cellular immunity. At
the age of 19 he was admitted with malaise and fever. An X-ray of the chest revealed a
pathological mediastinal mass, which proved to be non-Hodgkin lymphoma. He
received chemotherapy with prednisone and vincristine followed by maintenance with
methotrexate. The latter had to be discontinued after a year because of vomiting and
loss of weight. The disease remitted. At the age of 24, human immunoglobulin
substitution was started subcutaneously because of agammaglobulinaemia (IgG 1,37
g/l; IgM 0,22 g/l). At 27 years of age he had repeated fits with lowered consciousness.
Neurological examination was unremarkable. EEG showed low voltage activity, no
epileptic discharges. A hyperventilation provocation test was strongly positive.
Breathing control manoeuvres were beneficial. He is currently 30 and has no specific
complaints. 
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Figure 1.  Patient 1. Photograph at young age (A), and at adult age (B,C) 
A B C
Clinical and laboratory features of NBS
Patients and methods
We conducted a computer aided literature search to obtain data on patients with NBS
syndrome.1-11 Supplementary information was obtained from questionaires completed
by their attending physicians.
We now report on the available clinical and laboratory features of the 55 patients
included in the NBS registry to date.
Clinical features
Tables 1 and 2 summarise the clinical features of the patients 
Demography
The disease appears prevalent among those of eastern and central European origin,
particularly among Polish people. The 55 patietns comprise 31 men and 24 woman. 
Of the 55 patients, 36 are still alive; the oldest is now 30 years old (Table 1). 
Growth and development
All patient are microcephalic. Head circumference at birth varied between 26.5 and
36 cm. About 75% of patients had a birth head circumference below the 3rd centile, so
not all were microcephalic at birth. However, all developed progressive and severe
microcephaly during the first months of life. They have early growth retardation, height
falling below the 10th centile in all. The growth retardation is proportionate and weight
corresponds to height. Feeding difficulties are often reported in infancy probably due to
abnormal development of the mandible (see below). 
Developmental milestones were generally reached at normal times during the first
year of life. Hyperactivity was common. Mental development is normal in 40%, 50%
have borderline to mild retardation, while 10% are moderately retarded. Severe mental
retardation has not been reported. We found no correlation between head circumference
at birth and mental development. 
Few data are available about the sexual maturation of patients with NBS.3,12
Offspring have never been reported. Five patients have ovarian dysgenesis (patients 8,9,
20,26,53). 
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Table 1. NBS patients included in the NBS registry in Nijmegen
Patient Age at
no. Sex Origin Born death (y) Cause of death Gene mutation
1 M Dutch 1969 Sib of 2 657-661 del ACAAA
2 M Dutch 1964 6 Infection Sib of 1 657-661 del ACAAA
3 F Czech 1971 21 Malignancy Sib of 4 657-661 del ACAAA
4 M Czech 1977 2 Malignancy Sib of 3 657-661 del ACAAA
5 M Czech 1981 9 Malignancy Sib of 6 657-661 del ACAAA
6 F Czech 1980 0.5 Infection Sib of 5 657-661 del ACAAA
7 F Czech 1979 657-661 del ACAAA
8 F American 1965 24 Infection 657-661 del ACAAA
9 F German 1971 Sib of 10 657-661 del ACAAA
10 F German 1975 7 Infection Sib of 9 657-661 del ACAAA
11 M Dutch 1984 4 Lymphoma C>T at 976
12 F German 1985
13 F Czech 1983 6 Lymphoma
14 F Czech 1986 657-661 del ACAAA
15 M Polish 1980 Sib of 16
16 F Polish 1982 7 Lymphoma Sib of 15
17 M French-east Europe 1978
18 M Polish 1989 Sib of 19 657-661 del ACAAA
19 F Polish 1991 Sib of 18 657-661 del ACAAA
20 F Polish 1979 15 B cell lymphoma Sib of 21 657-661 del ACAAA
21 M Polish 1981 Sib of 20 657-661 del ACAAA
22 M Polish 1977 Sib of 23 657-661 del ACAAA
23 M Polish 1981 Sib of 22 657-661 del ACAAA
24 F Polish 1987 657-661 del ACAAA
25 M Polish 1993 657-661 del ACAAA
26 F Polish 1978 657-661 del ACAAA
27 M Polish 1986 Sib of 46 657-661 del ACAAA
28 M Polish 1991 4 B cell lymphoma 657-661 del ACAAA
29 M Polish 1982 657-661 del ACAAA
30 M Polish 1992 657-661 del ACAAA
31 M Polish 1989 8 Infection 657-661 del ACAAA
32 F English 1991 657-661 del ACAAA/698-701 del AACA
33 M English 1993 657-661 del ACAAA/698-701 del AACA
34 F Polish 1985 9 Medulloblastoma
35 M Polish 1980 657-661 del ACAAA
36 M Polish 1985 657-661 del ACAAA
37 M Canadian 1990 7 Rhabdomyosarcoma 657-661 del ACAAA/1142 del C
38 F Polish 1987 9 Lymphoma 657-661 del ACAAA
39 M Polish 1989 5 Lymphoma
40 M Polish 1993 657-661 del ACAAA
41 F Polish 1993 657-661 del ACAAA
42 M Italian 1985 11 B cell lymphoma 835-838 del CAGA
43 M Kroatian 1991 657-661 del ACAAA
44 M Kroatian 1996 657-661 del ACAAA
45 M German 1987
46 M Polish 1996 Sib of 27 657-661 del ACAAA
47 F Polish 1988 657-661 del ACAAA
48 F Polish 1993 657-661 del ACAAA
49 F Polish 1978 20 Lymphoma 657-661 del ACAAA
50 F Polish 1993 657-661 del ACAAA
51 F Polish 1989 657-661 del ACAAA
52 M Polish 1995 657-661 del ACAAA
53 F Polish 1978 657-661 del ACAAA
54 M New Zealand 1983
55 M Spanish-English 1995 657-661 del ACAAA
Craniofacial findings
All patients have a typical distinctive facial appearance, characterised by a receding
forehead, prominent mid face with long nose and long philtrum, receding mandible,
upward slanting palpebral fissures usually accompanied by epicanthic folds, freckles on
the cheeks and nose, large ears with dysplastic helices, and sparse hair (Fig 1). These
characteristics become more obvious with age. Subtle scleral telangiectasia is seen in
some. 
Cutaneous manifestations
Café-au-lait spots, vitiligo, sun sensitivity of the eyelids and pigment deposits in the
fundus of the eye are common. Cutaneous telangiectasia is seen ocassionally.
Congenital malformations
The most common malformations are clinodactyly and/or syndactyly noted in about
50% of the patients. Less common are anal atresia/stenosis (patients 9,10,31,45),
ovarian dysgenesis (patients 8,9,20,26,53), hydronephrosis (patients 2,7,11),and hip
dysplasia (patients 11,28,49,53). Other malformations reported are hypoplastic trachea
(patient 50), cavernous angioma (patient 46), agenesis of phalanges (patient 34),
hypospadias (patient 37), left renal hypoplasia (patient 45), and single kidney (patient
-83-
Nijmegen breakage syndrome: clinical and laboratory features in 55 patients
30
35
40
45
50
55
60
0 1 2 3 4 5 6 16 18 20 24 48 72 14
4
16
8
21
62212108 14 19
2
12
096
age (months)
cm
Figure 2.  Patient 1: Head circumference values in relation to age (lines represent 90th, 50th and 10th
centile values).
41). Cerebral malformations reported are schizencephaly (patient 37), occipital cyst
(patient 17), and hydrocephalus (patients 11,46).
Infections
Infections are common, most frequently of the respiratory tract followed by urinary
tract infections. Gastrointestinal infections are reported relatively infrequently.
The infections are typically community acquired infections rather than opportunistic
infections.
Malignancies 
To date 22 patients, varying in age from 1 to 22 years have developed a malignancy.
Of these, 16 developed a lymphoma (patients 1,3,4,5,9,11,13,16,20,27,28,35,38,39,42,
49), the majority B-cell. The remaining six have leukaemia (patient 54), precursor T-
cell lymphoblastic lymphoma/leukaemia (TLBL/ALL) (patients 29 and 51), glioma
(patient 7), medulloblastoma (patient 34) or rhabdomyosarcoma (patient 37). Eight of
the 22 patients with malignancy are still alive, including the patient described in this
case report. 
Laboratory features
Alphafetoprotein concentrations
In contrast to the situation with AT, all NBS patients had normal serum
alphafetoprotein concentrations.
Immunological disturbances
Figure 3 shows concentrations of IgG, IgA, and IgM, measured in 48 patients. 
The most commonly reported defects in humoral immunity were IgG and IgA
deficiency, as well as IgG2 and IgG4 deficiency. IgM deficiency was very rare.
Agammaglobulinemia was found in 16 patients (patients 2,3,5,8,17,18,27,29,31,36,40,
41,43,46,48,55). Selective IgA deficiency was seen in five patients (patients 1,9,10,14,
54). IgA deficiency as well as IgG2 deficiency with or without IgG4 deficiency was
noted in seven patients (patient 13,25,28,34,38,42,47). IgG2 deficiency with or without
IgG4 deficiency was seen in 11 patients (patients 7,11,19,20,21,22,23,24,35,52,53).
Selective IgG4 deficiency was noted in three patients (patients 32,45,51). Only six
patients had normal immunoglobulins (patients 12,26,30,37,49,50). 
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Table 2. Clinical features reported in NBS
growth and development
microcephaly 55/55
growth retardation 55/55 
craniofacial features
receding forehead 52/52 
prominent midface 
with long nose and philtrum 47/47
receding mandible 47/47
epicanthic folds 36/51
sparse hair 26/35 
large ears 24/29 
subtle scleral telangiectasia 8/25 
intelligence
normal intelligence 22/55
borderline to mild retardation 28/55 
moderate retardation 5/55 
skin abnormalities
cafe-au-lait spots 18/21 
vitiligo spots 14/21
sun sentivity of eyelids 10/19
pigment deposits in eye fundus 8/17
cutaneous telangiectasia 3/32
congenital malformations 
clinodactyly 22/34
syndactyly 12/36
anal atresia 4/55
hydronephrosis 3/55
hipdysplasia 3/55
others 10/55
infections
bronchopneumonia 38/50
otitis 17/33
urinary tract infections 13/20
sinusitis 9/30
gastro-intestinal tract infections 3/3
malignancies
lymphoma 16/55
leukemia 1/55
lymphoblastic lymphoma/leukemia 2/55
medulloblastoma 1/55
rhabdomyosarcoma 1/55
glioma 1/55
For some patients not all data were avalaible: in four patients with IgA deficiency IgG
subclasses were not determined; in three patients with normal immunoglobulins IgG
subclasses were not determined.
Figure 4 shows the percentages of CD3, CD4, and CD8 cells of about 70% of the
patients. The most commonly reported defects in cellular immunity were reduced
percentages of total CD3+cells and CD4+cells and a decreased CD4+/CD8+ ratio. The
frequency of CD8+cells usually does not appear to be affected. The in vitro response of
lymphocytes to mitogenic stimuli such as phytohemagglutinin (PHA) was decreased in
nearly all NBS patients tested (of 51 patients tested 47 had a greatly reduced response,
two patients had a slightly reduced response, and two had a normal response). 
Cytogenetic features 
Constitutional karyotypes of NBS patients are normal. Cultured T cells often show a
poor proliferative capacity, making cytogenetic analysis far from easy. In all patients
cytogenetic aberrations are present in 10-45% of metaphases from PHA-cultured T
cells. Most of the rearrangements occur preferentially in chromosomes 7 and 14 and are
typically inversions and translocations with breakpoints at the sites of immunoglobulin
or T cell receptor genes. Inv(7)(p13q35) is the most frequently detected aberration in
NBS. Other frequent rearrangements are t(7;14) (p13;q11), t(7;14) (q35;q11), t(7;7)
(p13;q35), and t(14;14) (q11;q32).5,7,11,15,16
Chromosomal rearrangements typically are not increased in cultured fibroblasts from
NBS patients and, in cases where increased rearrangements in fibroblasts are reported,
no bias in the sites of rearrangement analogous to that in lymphocytes is observed.
Radiation hypersensitvity and radioresistant DNA synthesis
Primary cells (fibroblasts and lymphocytes) cultured from NBS patients typically
display poor growth in culture, a feature they share with cells from ataxia telangiectasia
patients. In addition, primary cells and transformed cells have aberrant responses to
ionising radiation. In colony forming assays, NBS cells are 3-5 times more sensitive to
ionising radiation or radiomimetic drugs than normal cells. Radiation induced
chromosome aberrations occur with increased frequency in NBS cells. X-ray
hypersensitivity was present in 26 out of 27 patients tested (patients 1,3,5,7-12,14,18,
20-24,27-29,32,33,36,37,45,47,53). One patient showed intermediate sensitivity
(patient 42). 
NBS cells also display radioresistant DNA synthesis (RDS), the inability to halt or
slow S phase progression after exposure to high doses of X-rays. The inhibition of DNA
synthesis after X or gamma irradiation is two to three times less pronounced than in
normal cells.7,11,14,16,18
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Necropsy findings
Nineteen of the patients have died, five from infection, and 14 from malignancy.
Limited autopsy findings are available: an extensive post-mortem examination has been
reported for only one patient, a 4-year old child (patient 12), in whom brain weight was
extremely reduced. There was no evidence of cerebellar degeneration. The thymus was
small, dysplastic and relatively devoid of lymphoid cells. Limited necropsy data from
other patients confirm small brain, thymus dysplasia or even thymus aplasia.2,13
Genetics
Registered patients come from 44 families, the majority of Eastern European
ancestry. Recent genetic studies have provided evidence for a common haplotype of
markers present in the families with Eastern European origins suggesting a common
founder effect with regard to mutations causing the disorder. After identification of the
gene, mutation detection has revealed a truncating 5 bp deletion, 657-661delACAAA,
as the disease causing mutation in these patients (see table). Five further truncating
mutations were identified in patients with other distinct haplotypes. Four of these
mutations are listed in the table. The fifth, a 842-843insT, was identified in a Mexican
patient, who has not yet been registered.
Patients with different genotypes may show the same phenotype, as illustrated by
patients 2 and 11 both showing hydronephrosis, by patients 7 and 37 both showing
severe Tcell immunodeficiency, and by patients 11 and 20 both having developed a
lymphoma. On the other hand, patients with the same genotype may vary in phenotypic
expression, as illustrated clearly by patient 1 who only has an IgA deficiency and is still
quite healthy, while his older brother had agammaglobulinaemia and died young from
infection. Other examples are: patient 18 has clinodactyly, patient 19 does not; patient
20 developed a glioma, while patient 21 is still free of malignancy. 
Discussion
The hallmarks of NBS are microcephaly, a typical facial appearance, growth
retardation, immunodeficiency accompanied by recurrent infections, chromosomal
instability, X-ray hypersensitivity and predisposition to malignancy. Important
additional features are skin abnormalities particularly cafe-au-lait spots and vitiligo, and
congenital malformations, particularly clinodactyly and syndactyly.
Psychomotor development is usually normal or only mildly to moderately retarded
despite severe microcephaly. This is in contrast to the severe mental impairment
commonly seen in isolated or autosomal recessive non-syndromal microcephaly. About
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three-quarters of the NBS patients are microcephalic at birth and the remainder become
microcephalic within the first year of life. No correlation can be seen between head
circumference at birth and mental development. Severe microcephaly at birth may be
associated with normal mental development and counterwise. 
Life expectancy is reduced because of their tendency to develop malignancies at a
relatively young age and sometimes fatal infections.
Remarkably, despite the often severe immunodeficiency, frequently occurring
infections rarely lead to severe complications. Moreover opportunistic infections are
very sparse despite the T cell defect, as also experienced in ataxia telangiectasia (AT),
which has similar T cell defects.
About 40% of the patients included in the NBS registry have developed a malignancy,
predominantly in childhood. Treatment may be difficult, because of hypersensitivity to
ionising radiation and radiomimetic drugs, which may have to be avoided or used at
reduced dosages.18
The immunological, cytogenetic, and cell biological findings in NBS closely
resemble those in AT (see table 3). Therefore NBS has long been considered as an AT
variant.19-25 Concerning the clinical aspects, however, NBS is more similar to Bloom
syndrome (BS), both of which encompass severe microcephaly with relatively
preserved mental development. Unlike AT, neurological features are rare. The facial
appearance is different, being small and narrow in BS. NBS and BS lack the increased
serum alphafetoprotein (AFP) concentrations of AT. BS shows a characteristic
cytogenetic feature, the sister chromatid exchanges, which is not seen in NBS and
AT.19-25,29
The specific pathogenesis of the disorder still has to be elucidated, despite recent
identification of the gene.26-28
This has had immediate implications for diagnosis and family studies. Studies on the
gene product, nibrin, have provided a key to new fundamental knowledge on the
molecular mechanism of double strand DNA break repair. Comprehensive sequence
comparison of nibrin has revealed two domains in the amino terminal region: a
forkhead-associated domain (FHA) and a breast cancer carboxy terminal domain
(BRCT). Both domains have been found separately in DNA damage-responsive cell
cycle checkpoint proteins. Carney et al.28 provided evidence that nibrin can form
complexes with two proteins that play a role in double-strand break DNA repair. This
suggests that deficiency in nibrin disrupts a common pathway that functions to sense or
repair double-stranded DNA breaks.
DNA double-strand breaks occur often but seldom lead to aberrations in case of a
normal functioning repair mechanism. In the case of dysfunction of repair mechanisms,
however, serious aberrations can be expected, particularly in tissues with high
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proliferative capacity. In that light, congenital deformations, immunodeficiency,
radiation hypersensitivity and cancer predisposition are comprehensible. 
In DNA repair disorders immunodeficiency, growth retardation and predisposition to
malignancy are common, both in man and in animals with Ku70 and Ku80 deficiency.
In Ku70 and Ku80 deficient mutants an abnormal sensitivity to ionising radiation and a
severe combined immunodeficiency due to abnormal V(D)J recombination exist.
Immunoglobulin heavy chain rearrangements in a NBS lymphoblastoid cell line have
been analysed by DNA sequencing and found to be normal.30 However, quantitative
analysis in NBS cells is required to address adequately the role of the hMrell/hrad 50
protein complex in this process.28 As IgM level is nearly always normal in NBS,
whereas IgG and IgA levels are frequently abnormal, this suggests that the gene may be
involved in this process during the isotype switch. 
No specific genotype-phenotype relation has been identified. NBS registry patients
with the same genotype may display different phenotypes and patients with different
genotypes may express the same phenotype. Defects in sensing and repairing double-
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Table 3. Comparison of Nijmegen breakage syndrome (NBS) with Bloom syndrome
(BS) and ataxia telangiectasia (AT)
NBS BS AT
Gene locus 8q21 15q26 11q22-23
Gene NBS1 BLM ATM
Microcephaly ++ ++ -
Growth retardation ++ ++ ±
Mental retardation ± - ±
Typical facial appearance ++ - -
Telangiectasia
Ocular ± - ++
Cutaneous ± + ++
Skin abnormalities
Hyperpigmentation + + +
Sunlight sensitivity + ++ -
Cerebellar ataxia - - ++
Recurrent infections ++ ± ++
Elevated AFP levels - - ++
Immunodeficiency ++ + +
Cancer predispostion ++ ++ +
Chromosomal instability ++ ++ ++
Radiation hypersensitivity ++ - ++
- = absent; ± = rare ; + = usual; ++ = frequent
stranded DNA breaks by nibrin on several specific places of the genome as well as the
interplay with other gene products, involved in DNA double strand repair, may be the
explanation for this feature. 
Finally, specific mutations do not lead to specific clinical features. For example a
specific mutation predisposing to malignancy is not seen. 
It is interesting that within the same genotype clinical and laboratory features may
differ. Obviously compensating mechanisms play a role. Insight in these mechanisms
probably would offer new approaches for therapeutic interventions.
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Abstract
Nijmegen breakage syndrome (NBS) is a rare chromosomal-instability syndrome
associated with defective DNA repair. Approximately 90% of NBS patients are
homozygous for a truncating mutation of the NBS1 gene. As development of the
immune system relies on recombination, which involves repair of DNA breaks, one
might predict that mutations in the NBS1 gene could cause immunodeficiency. We
immunologically investigated the world’s largest series of NBS patients (n=74),
confirmed immunodeficiency, and found a discrepancy between relatively normal IgM
concentrations, and decreased IgG and IgA concentrations. In addition, a significant
relation between low IgA and low IgG levels was found. These data are compatible with
a defective class switching in NBS and can be explained by a role of the NBS1 protein
in DNA repair, signal transduction, cell cycle regulation or apoptosis.
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Introduction
Nijmegen breakage syndrome (NBS) is an autosomal recessive disease, characterised
by microcephaly, growth retardation, immunodeficiency, chromosomal instability,
cancer predisposition, ionising radiation sensitivity, and cell cycle abnormalities.1,2,3
The gene that is affected in these patients, NBS1, was recently identified on
chromosome 8q21.4 It encodes a protein called nibrin, which was found to form a
complex with the hRad50 and hMre11 proteins. 
The hRAD50 and hMRE11 genes are conserved from yeast to humans. In yeast this
protein complex is clearly involved in DNA double-strand break (DSB) repair. DSBs
can either be repaired by homologous recombination, which uses the homologous
chromosome or sister chromatid as a repair template, or by DNA end-joining, which
does not make use of a homologous sequence to align the DNA ends. Which of these
two major DNA double-strand break repair pathways is affected in NBS remains
unknown. In yeast, both pathways are impaired upon deletion of either the hRAD50 or
hMRE11 gene, but the equivalent gene disruptions in mammals are not viable.5
Although the function of the nibrin component of this complex is not fully
understood, it is clear that NBS cells show defects in cell-cycle regulation and/or DNA
damage detection.4,6,7 The interpretation of these data is complicated by the fact that
NBS patients are not complete null mutations. Approximately 90% of NBS patients
harbour a 5 bp deletion, resulting in production of a truncated form of the nibrin
protein.8 This truncated protein is probably partially functional,8 as NBS1 knock out
mice are not viable.9
As argued above, the hRad50/hMre11/Nbs1 complex is most probably directly
involved in DNA double-strand break repair. As development of the immune system
relies on recombination which involves repair of DNA breaks, one might predict that
mutations in the NBS1 gene could cause immunodeficiency.10 We previously published
clinical and immunological data on the world’s largest cohort of NBS patients.3 In the
present study we extend the number of NBS patients, correlate the various
immunological findings and interpret the differences in immunoglobulin class
concentrations in the light of novel insights in the role of nibrin in DNA repair. 
Patients and methods
Up to now, 74 European patients diagnosed with NBS using established criteria, are
included in the NBS registry, held at Nijmegen.3 In these patients humoral and cellular
immunity were studied, in some of them at various ages. Ig levels and percentages of
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T-cell populations were measured using standard techniques as previously described.3
Results
We previously reported immunologic abnormalities in NBS patients.3 In this paper we
extend the number of patients that have been tested for various parameters (Figure 1).
We found that IgM levels were normal or even slightly elevated (2/54 had
concentrations below P5). However, IgA, IgG and IgG2 levels were decreased in most
patients (17/55, 27/58 and 18/55 had concentrations below P5), suggesting a defect in
Ig heavy chain class switching. Indeed, a significant correlation existed between the
concentrations of IgG and IgA in the same patient (r = 0.57; p < 0.0001), whereas this
was not the case for IgG and IgM (r = -0.13; p = 0.2), and IgA and IgM (r = 0.019, p =
0.85). Elevated levels ( > P95) of IgG or IgA never occurred. 
In addition to this B-cell defect, we observed low percentages of CD4+ T-cells in most
NBS patients (30/41 had levels below the 5th percentile), although none of the patients
had a severe deficiency of CD4+ T-cells. However, the percentage of CD8+ T cells was
normal, suggesting that this defect does not reflect a decreased level of V(D)J
recombination. These data, nevertheless, should be interpreted with caution, because
only percentages of T cells were available, absolute numbers of T-cells were lacking,
As CD4+ T-cells might be required for efficient class switching, we investigated
whether the low levels of CD4+ T-cells correlated with low IgA or IgG levels. No
correlation existed between the percentages of CD4 cells and IgG (r = 0.16; p = 0.35),
or IgA (r = 0.22; p = 0.19).
Discussion
The most remarkable finding of the present study on the world’s largest series of NBS
patients is the discrepancy between the relatively normal IgM concentrations, and the
decreased IgG and IgA concentrations. Although we did not test the process of
immunoglobulin class switching directly, our data on immunoglobulin class
concentrations in the largest cohort of NBS patients ever, are compatible with a
defective isotype switching. In addition, low IgG levels are significantly linked to low
IgA levels in the same patient, favoring the interpretation of defective class switching
from IgM to IgG and IgA. Although immunodeficiency has recently been published by
our study group,3 this correlation provides additional evidence for a direct inhibition of
the class switching mechanism in NBS patients. 
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Figure 1. Serum immunoglobulin (IgG, IgA and IgM) concentrations in NBS patients compared with
P5, P50 and P95 reference values.
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We considered several possibilities for the low levels of IgA and IgG in the blood of
NBS patients. First, we considered a general defect in the non-homologous end-joining
pathway of DNA double-strand break repair. The antigen receptors of mature B and T
lymphocytes are produced by a recombination process that rearranges V, D, and J gene
segments into the V(D)J exon encoding the variable domain. After V(D)J
recombination, the heavy-chain locus is organised for production of IgM antibodies.
Subsequently, B cells can switch to production of other classes of heavy chains (e.g.
IgA or IgG) by deleting the DNA segment encoding the Mu constant region.
Components of the DNA-dependent protein kinase (DNA-PK) are required for V(D)J
recombination, class switching and repair of radiation-induced breaks in the DNA,11
suggesting that class switching involves a DNA end-joining reaction. However, we
discarded the possibility that NBS patients have a general defect in DNA end-joining,
because V(D)J recombination is both quantitatively and qualitatively normal in these
patients.11
Second, we considered the possibility that class switching is impaired because of the
absence of proper stimulation caused by low levels of CD4+ cells. V(D)J recombination
is an autonomous process, not dependent on CD4+ T-helper cells, whereas class switch
recombination is dependent on T-cell help. If the class switching defect would be
caused by the low level of CD4+ cells, one would expect that low levels of IgA and IgG
would correlate with low percentages of CD4+ T cells. Although in present study only
percentages, in stead of absolute numbers, of T cells were available, we could not find
indications for decreased T-helper cells, suggesting that the absence of T-helper cells
can not be the only explanation for the decreased class switching.
We therefore favour the interpretation that the nibrin protein is involved in another
process that is specifically required for immunoglobulin class switch recombination.
Nibrin could either directly be involved in the DNA repair step or it might have a role
in a more regulatory function, such as signal transduction, cell cycle regulation or
apoptosis. The increased levels of chromosomal aberrations in NBS patients suggest
that they have a defect in DNA recombination and repair. Especially the frequent
rearrangements (14%) of chromosome 7 and 14 12, which include the immunoglobulin
heavy chain locus and the T cell receptor beta and gamma gene loci, could be explained
by DSB repair gone awry.
However, it is also possible that the NBS defect could be found in defects in cell cycle
regulation or apoptosis. The apparently normal percentages of B and T cells with
rearranged immunoglobulin and T-cell receptor loci does not necessarily mean that the
efficiency of V(D)J recombination is completely normal. Even a much lower efficiency
in this recombination reaction might be compensated by increased numbers of
precursor cells that attempt V(D)J recombination, followed by selection of the
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productive rearrangements. If increased apoptosis would happen in switching B-cells,
this might easily result in decreased levels of B-cells which produce IgA and IgG. It is
possible that the repair defect in B cells that attempt class switching results in
accumulation of unrepaired breaks, which might trigger apoptosis. This would quickly
remove these differentiating cells from the pool of lymphocytes, resulting in normal
IgM and decreased IgG and IgA levels. Discrimination between these possibilities will
require development of a good animal model that mimics the human NBS mutation.
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Abstract
Nijmegen breakage syndrome (NBS) is an autosomal recessive disorder, due to
defects in the NBS1 gene and belongs to the DNA repair disorders. We report
neuropathological findings of the first ever recognised case of the about 60 described
cases of NBS. This patient showed severe microcephaly with a simplified gyral pattern
especially in the frontal lobes. There were no signs of a degenerative disease, or of a
primary migration disorder. A bulge on top of the corpus callosum, most probably a
very large remnant of the involuting striae longitudinales mediales et laterales, was
found. This can be considered as an incomplete development of limbic structures. The
severe diminishment of neocortical neurons suggests an important role for the NBS1
gene in corticogenesis in man, as suggested earlier in animal studies of other DNA-
repair genes. 
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Introduction
Nijmegen breakage syndrome (NBS) is a rare autosomal recessive multisystem
disorder belonging to the family of the DNA repair disorders.15 It is characterised by
microcephaly, a typical facial dysmorphology, immunodeficiency, X-ray hyper-
sensitivity, and predisposition to cancer (see 13 for references). The gene responsible
for NBS, NBS1, is located on chromosome 8q21 and encodes a protein called nibrin.
This protein is a component of the hMre11/hRad50 protein complex that is important
in the repair of DNA double strand breaks.
Recently, the clinical and laboratory data of 55 patients included in the NBS registry
in Nijmegen were reported.13 All patients showed microcephaly. Three quarters were
microcephalic at birth, while the remainder developed progressive and severe
microcephaly during the first months of life. The cause of microcephaly in NBS is still
unclear, but apparently, DNA double strand break repair plays a role in cerebral
corticogenesis. Support for this hypothesis is found in animal studies.7,5
Limited autopsy findings are available in NBS, particularly concerning
neuropathological findings, reporting small brains and reduced brain weight.14 In this
report, we describe more extensively the neuropathological findings of the first NBS
patient recognised in 1981. We discuss the possible pathophysiologic mechanisms
leading to the microcephaly in the light of recent insights in DNA-repair disorders.
Materials and Methods
Case history
The patient’s medical history until the age of 30 years has been previously described
(patient 1 in reference 13) and can be summarised as follows. He was born after a
pregnancy of 38 weeks. Microcephaly was noted when he was 6 weeks old. Head
circumference remained below P3. Language skills were delayed. He showed
behaviour disturbances and learning difficulties necessitating special school education.
Epileptic manifestations were never noted. Total IQ at age 9 years. (Dutch version of
Wechsler Intelligence Scale for Children-Revised) was 67. Neurological examination
was unremarkable; particularly pyramidal signs were lacking. At the age of 19, he was
successfully treated for non-Hodgkin lymphoma. At the age of 24, immunoglobulin
substitution was given because of agammaglobulinaemia. At the age of 31, he
developed abdominal complaints due to ileus. At surgery, carcinomatous peritonitis was
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observed. There were no therapeutic opportunities. He died several weeks later from
cachexia. At autopsy metastasising adenocarcinoma of the colon was found.
Electrophysiology
Repeated EEGs during life revealed no abnormalities except for low voltage
background activity. Epileptic discharges were not present.
Magnetic resonance imaging (MRI)
Cerebral MRI performed at 27 years. of age revealed pronounced microcephaly. The
viscerocranium was relatively large. The volume of the frontal lobes was very small.
Overall, but particularly in the frontal lobes, the gyral pattern looked simplified.
Furthermore, slight atrophy of the cerebellar vermis was noted. The size of the
ventricles was within normal range. No white matter abnormalities were seen. The
corpus callosum looked normal both on sagittal and frontal sections, including the
anterior part of it bordering on the lamina terminalis (Figure 1).
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Figure 1. Sagittal cerebral MRI 3 years before the death of the patient: overall small neurocranium in
comparison with viscerocranium, especially small frontal lobe, simplified gyral pattern, slight atrophy of
the cerebellar vermis, normal corpus callosum.
Post-mortem examination of the brain 
The brain was removed 15 hours after death. A classical neuropathological
examination was performed. Apart from samples for paraffin embedding from multiple
sites, one block encompassing both hemispheres at the level immediately in front of the
mamillary bodies was embedded and whole sections at this level were made. Sections
were stained with HE and HE-Luxol fast Blue. Cortical slides were stained en plus with
cresyl violet. Slides from selected areas were stained with Bodian’s silver stain and with
antibodies against AT8-Tau (Innogenetics, Ghent, Belgium), CD68, Glial fibrillary acid
protein, ubiquitin and A4-amyloid (all Dako, Glostrup, Danemark).
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Figure 2a to d. a. Right lateral view of the brain. Small frontal lobe, simple convolutional pattern of
the temporal lobe; b and d Frontal slice of brain at the level of the head of the caudate nucleus (b) and at
the level of the substantia nigra (d). Simple convolutional pattern. The ventricles are not dilated. Presence
of striae longitudinales and indusium griseum (arrow). c. Small inferior vermis.
Results
At autopsy, the brain was small and weighed 735 g (normal 1250-1350 g); especially
the decreased size of the frontal lobes was striking (Figure 2). No obvious gyral atrophy
was seen. The gyral pattern looked simplified (Figures 2a, 2b and 2c). Primary and
secondary gyri were normally present, but the number of tertiary gyri was reduced. The
latter became even more obvious on frontal slices (Figures 2b and 2d). The white matter
had a reduced volume; the cortex was normally thick. The lateral ventricles were
slightly enlarged. A 6-mm broad and 3.5-mm high triangular band was seen on top of
the corpus callosum over its whole length (Figures 2b and 2d). The brain stem and
cerebellum had a relatively greater volume than the supratentorial part of the brain. The
inferior vermis was smaller than normal (Figure 2c).
On microscopic examination the band on top of the corpus callosum consisted of
longitudinal bundles of white matter, a small indentation probably dividing it into two
parts (Figure 3a). Very few scattered neurons (Figure 3a, insert) were seen in this band.
The neocortex had a simplified structure: the normal 6 horizontal layers could be found.
The neurons were slightly more densely packed than normal and had a somewhat
columnar orientation in the frontal lobe (Figure 3b). There were no abnormally
migrated neurons seen. There was no gliosis, macrophage proliferation, obvious
neuronal necrosis, apoptosis or shrinkage. The basal ganglia and white matter seemed
normal. In the vermis several abnormally located Purkinje cells, that were slightly
smaller than the normally situated Purkinje cells could be found within the internal
granular cell layer. This was more pronounced in the inferior vermis than in the superior
vermis. There was slight gliosis of the granular cell layer of the inferior vermis, that was
slightly less dense than normal. Immunohistochemical examination did not reveal
abnormal neuronal or extraneuronal accumulation of ubiquitin or A4-amyloid.
Discussion
In clinical practice microcephaly is often defined as a condition in which the size of
the head, measured along the occipito-frontal circumference (OFC) is more than 2
standard deviations below the mean; extreme microcephaly has been defined as OFC of
3 or more standard deviations below the mean.1 The present patient has severe
microcephaly with simplified gyral pattern, normal cortical thickness and normal
myelination. He belongs to the least affected group of patients with severe
microcephaly and simplified gyral pattern according to the recent classification of
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Dobyns and Barkovich.6 Our patient had no severe mental retardation, and showed no
epilepsy, this is in line with that classification.
Microcephaly can be due to environmental and genetic causes.12 Environmental
causes include congenital infections, intrauterine exposure to teratogenic agents and
hypoxic-ischaemic injury . Genetic origins are quite heterogeneous: several autosomal
recessive microcephaly loci have been mapped; microcephaly is also seen in
association with chromosomal abnormalities or other well-defined genetic syndromes,
such as Miller-Dieker syndrome, X-linked mental retardation, Smith-Lemli-Opitz
syndrome, and other (see Ref. 12 for review). Microcephaly can be present at birth
(congenital microcephaly) or can have its onset after birth (commonly referred to as
acquired microcephaly). The latter is commonly seen in hereditary metabolic disorders.
In those cases the head circumference is normal at birth but does not increase normally.
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Figure 3a and b a. Histological slide of the striae longitudinales and indusium griseum. The arrow at
the indentation probably marks the division between right and left (Luxol fast blue-HE; Bar = 2 mm).
Insert: neuron found in the marked area (cresyl-violet; Bar = 50 µm). b. Histological slide of the neocortex
with columnar organisation of the neurons (cresyl violet; Bar = 2 mm).
The neuropathological findings of microcephaly and especially frontal lobe
hypoplasia corroborate earlier clinical and radiological findings in NBS,4 and were also
seen in the earlier pathological report of 2 NBS patients.14 Microcephaly in NBS has
most probably a genetic cause. We did not observe cortical gliosis, spongiosis or
ongoing neuronal necrosis, as we would normally expect in neuronal loss due to
environmental causes or due to hereditary metabolic disorders. Unfortunately, in the
patient described, no data on head circumference were available at birth; evidence
exists of severe microcephaly from age six weeks. The microcephaly is commonly
present at birth in NBS but not in all cases. If microcephaly develops after birth in NBS,
it seems to remain stable after the first months.4
Neuropathological findings in our patient revealed a relatively well preserved, but
simplified gyral pattern. This convolutional simplicity was most obvious in the frontal
lobes. The term oligogyric microcephaly 9 applies very well in the present case as there
is no sign of lissencephaly detected on macro- and microscopical examination and the
term “microlissencephaly”1 does not fit well. The development of the tertiary
convolutions takes place in the last 6 weeks of the intrauterine life and after birth. The
frontal lobes are the last to develop in this respect.8 The complex folding of the brain
allows the dramatic increase in cortical size in normal brain development. This
expansion of the cortex depends on several factors, one of that certainly is the formation
of multiple dendrites for evolving synapse formation. If this would be the only
responsible factor in the presented patient, one would expect a much higher density of
remaining neurons than is the case now. A second possibility is that the microcephaly
is due to a diminished number of cortical neurons, and a consequent diminished volume
of white matter.2 Both exogenic and genetic factors could result in such a diminished
number of neurons. In the latter case it has been speculated that genetic factors
impairing cell proliferation or apoptosis or both would be implicated.3
The NBS gene shows enhanced expression at the level of the telencephalic and
diencephalic periventricular matrix zones in the intrauterine period in the mice,16 at the
time when the proliferation of neurons takes place there. The relatively late occurrence
of microcephaly, sometimes even after birth pleads against a sole disturbance of
neuronal proliferation in NBS, because neuronal proliferation essentially takes place in
the first half of gestation. The role of cell death as the origin of the microcephaly,
however, must be considered more closely, although this remains difficult to prove in a
patient dying at the age of 31. Recently, it was observed that also factors involving the
cell cycle are important in the cortical size. Caspase-deficient murine embryos have an
increase in forebrain progenitor cells, which leads to a larger expansion of the cerebral
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wall and a convoluted cerebrum instead of a smooth brain.10 Citron kinase knockout
mice have important abnormalities in cell cycle regulation and increased apoptosis and
showed severe microcephaly.5 Mutant mice for another gene implicated in DNA repair,
Xrcc4, show a defect in neurogenesis and excessive apoptotic cell death of postmitotic
neurons.7 Presently, it remains a matter of speculation whether and how other
disturbances of the cell cycle, as in the case of DNA repair genes might influence this
cortical development. It is possible that NBS1 has additional functions in the cell
proliferation cycle to DNA repair. 
The longitudinal band on top of the corpus callosum was not observable on MRI,
probably due to the low resolution (M. van der Knaap, personal communication). It was
considered a remaining of the striae longitudinales mediales. As there were also a few
neurons present in this band it was considered that cells of the induseum griseum and
the striae laterales were also part of the structure, although it is unusual to find the
induseum griseum medial to the gyrus cinguli. The induseum griseum and the striae
longitudinales mediales et laterales are part of the supracommisssural hippocampus,
and normally involute during the foetal period One could hypothesize that some
neurons of the induseum griseum could be found displaced there because of the unusual
large size of the remaining structure. Alternatively one could speculate that the neurons
are remnants of the precommissural hippocampal formation taken to their present
ectopic medial position during the formation of the corpus callosum. The prominent
presence of the striae longitudinales and induseum griseum is a very rare phenomenon.
Presumably, the only similar finding was observed in cases with trisomy 13.11 In those
cases, however, it consisted principally of neurons, and myelin was not present, so it
was considered to be a remaining induseum griseum. According to a micro-photograph
(Figure 1) 11, it was also found medial to the cingular gyrus.
In reviewing the sections of another NBS patient (reported in reference 14, patient 1)
we could find comparable hyperplastic striae longitudinales, albeit in a lesser degree.
This failing involution of the striae longitudinales may be considered as a
developmental disturbance of the archicortical structures. The more simplified cortical
pattern with remaining columnar organisation might be another consequence of
developmental disturbance.
In the vermis slight developmental disturbances were found, including the presence
of some abnormally located and rather small Purkinje cells. These changes are far less
severe than those observed in ataxia teleangiectasia, another DNA-repair disease, and
are concurrent with the previous histopathological findings in NBS patients.14
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Introduction
Nijmegen breakage syndrome (NBS) is a rare autosomal recessive chromosomal
instability disorder characterized by microcephaly, immunodeficiency, X ray
hypersensitivity and predisposition to malignancy. The gene responsible for NBS,
NBS1, is located on chromosome 8q21 and encodes a protein called nibrin. This protein
is a component of the hMre11/hRad50 protein complex, suggesting defective DNA
double strand break (DSB) repair or cell cycle checkpoint function in NBS 1-7. In this
report we describe a patient with the NBS phenotype, typical cytogenetic presentation
with aberrations in chromosome 7 and 14, and an increased X ray sensitivity. Our index
patient had deafness unlike all the other NBS patients reported so far. Mutation
detection did not show a mutation in NBS1 and the protein nibrin was normal expressed. 
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Case report
The boy is the second child of non-consanguineous parents. His older sister is healthy.
From the sixth month of pregnancy microcephaly and growth retardation were noted.
Amniocentesis was performed followed by a cytogenetic study which showed a normal
male karyotype. He was born in 1997 at 39 weeks of gestation. Birth weight was 
1915 g, length 42 cm and headcircumference 28.5 cm (all below the 3rd centile). The
neonatal period was complicated by a mild hypoglycaemia. During the first year of life
he suffered from feeding difficulties and vomiting for which no specific cause was
found. Developmental milestones were markedly delayed in language skills because of
a severe hearing deficit. Motor skills were reached within the normal range. Head
circumference remained below the 3rd centile. 
At 20 months of age he was examined in our hospital. On examination, he was a small
microcephalic boy with hearing aids on both sides. Head circumference was 40.2 cm,
weight 8.2 kg and height 77 cm. He had large ears, epicanthic folds, and a receding
mandible (Figure 1). On his back two hyperpigmentation spots were noted. Apart from
speech delay, neurological examination was normal. EEG showed no abnormalities. A
CT-scan of the os petrosum showed severe dysplasia of the cochlea. Cerebral MRI
showed no structural lesions. The extent of myelinisation was considered normal for
age. Routine blood tests were normal, as were endocrinological studies and aminoacid
levels.
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Figure 1. Facial appearance of the patient
Immunological studies showed IgG4 deficiency, but the immunoglobulins were
otherwise normal: IgG 7.41 g/l, IgG1 6.38 g/l, IgG2 0.89 g/l, IgG3 0.60 g/l, and IgG4
not detectable; IgA 0.68 g/l; IgM 0.80 g/l; IgE 17U/ml. T-cells were within normal
range and both percentages and absolute numbers of CD3, CD4 and CD8 cells were
normal. The in vitro response of peripheral blood lymphocytes to the mitogen
phytohemagglutinin was depressed. Specific antibodies after immunisation (Diphteria
toxoid, Tetanus toxoid and Hemophilus influenza B) were normal.
Cytogenetic studies showed in 50 cells one typical translocation 7;14 (t(7;14)
(p13;q11) and one inversions 14 (q11;q32). Moreover, 88% of cells showed multiple
chromosomal aberrations after exposure to X rays (1.0 Gray) compared to 18% of cells
from a normal control. 
Mutation detection using genomic DNA was performed by PCR with specific primers
for the human NBS1 gene, followed by automated DNA sequence analysis of the entire
open reading frame of both DNA strands. No mutations or polymorphisms were
observed in the NBS1 gene of our index patient.
In western blotting experiments, all NBS1 mutations in NBS patients are predicted to
result in truncation of the protein product nibrin 4. For this reason, western blotting was
used to assess the quantity and quality of nibrin expressed in lymphoblasts from the
patient (Figure 2). A normal level of correctly sized nibrin was detected, consistent with
the results of the molecular genetic studies.
Discussion
NBS belongs to the family of DNA repair disorders. Other members are Bloom
syndrome (BS) and ataxia telangiectasia (AT). All of these disorders show
chromosomal instability, immunodeficiency and predisposition to cancer, but are
genetically heterogeneous, involved in different pathways of DNA repair. The gene for
NBS (NBS1), has been identified on chromosome 8q21, the gene for BS ( BLM) on
chromosome 15, and the gene for AT (ATM) on chromosome 11.3-6 Apparently, different
proteins encoded by different genes play a role in cycle cyclus control. Although
identification of the genes has been very helpful, the specific patho-physiological
mechanisms have still to be elucidated. 
-118-
Chapter 8
The patient presented here fullfils the criteria for NBS namely microcephaly, growth
retardation, immunodeficiency (although very mild), typical chromosome 7 and 14
aberrations, and X ray hypersensitivity (Table 1). His face with receding mandible and
epicanthic fold is in keeping with the typical appearance, which usually becomes more
obvious with age. At the molecular and protein level, however, the patient shows
completely normal results and thus does not fit into the NBS spectrum as described
previously. This strongly suggests the presence of another gene, a NBS-like gene.
Another family with the NBS phenotype, but without linkage to chromosome 8 has
been described by Cerosaletti et al. 6 (Table 1). The proband had microcephaly, growth
retardation, unusual facial features, mild radial cataracts and diffuse abnormal skin
pigmentation. Deafness was not mentioned. Immunoglobulin levels, B and T cells were
normal as in our patient. In NBS nearly all patients have disturbances of serum
immunoglobulins and T cell subpopulations. 
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Figure 2. Western blot showing normal level of nibrin. Lane 1 is the size standard. Lanes 2, 3 and 4 are
serial dilutions of a normal control B cell line. The lanes contain 5 x 10E5, 2.5 x 10E5 and 1 x 10E5 cell
equivalents. All the remaining lanes on the blot contain 5 x 10E5 cell equivalents. Lane 5 is a NBS patient
lacking nibrin. Lane 6 is our index patient with normal nibrin expressed. Lane 7 and 8 are control patients,
and lane 9 is a patient with ataxia telangiectasia. 
Hearing loss is seen in many syndromes with microcephaly, but until now it has not
been reported in NBS.7 Many congenital disorders have been found in some, but not all
patients of the group with the Slavic mutation.7 The finding of hearing loss may be
coincidental. However, specific congenital anomalies such as hearing loss in our patient
and cataract in the patient of Cerosaletti et al may be symptoms of other NBS disorders.
Identification of the gene involved (NBS2) will be an important step forward in
unraveling these questions. 
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Table 1. Clinical and laboratory data.
Our patient Patient NBS
ref 6 Literature
Microcephaly + + +
Growth retardation + + +
Mental retardation + - +
Typical facial appearance + + +
Skin abnormalities + + +
Deafness + - -
Cataract - + -
IgG g/l normal Normal decreased
IgA g/l normal Normal decreased
IgM g/l normal Normal decreased
CD3 cells normal Normal decreased
CD4 cells normal Normal decreased
CD8 cells normal Normal normal
NK cells normal not determined increased
Chromosomal instability
- 7/7 rearrangements + +
- 7/14 rearrangements + +
- 14/14 rearrangements + +
Radiation hypersensitivity + + +
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In this chapter the main findings of our studies on AT and NBS will be discussed and
suggestions for future research will be made.
Ataxia telangiectasia
Ataxia telangiectasia is a rare autosomal recessive multisystem disorder characterized
by progressive cerebellar ataxia with onset in childhood, oculocutaneous telangiectasia,
immunodeficiency, radiation sensitivity and increased incidence of malignancy. Each of
these abnormalities presumably result from impaired protein function induced by the
mutation in the gene,responsible for AT, ATM (ATmutated).1-4
If AT is suspected, determination of serum alphafetoprotein level is the most helpful
screening procedure.5,6 In the appropriate clinical setting, the finding of a serum
alphafetoprotein level at least two standard deviations above normal in patients above
eight months of age, is diagnostic of the disorder, with a sensitivity of approximately 95
percent.7-9 When an increased alphafetoprotein level is found additional studies are
indicated, including immunological and cytogenetic studies as well as DNA studies
(chapter 1). 
The reason for the increased level of alphafetoprotein in AT is still unclear.
Alphafetoprotein is a major plasma glycoprotein in developing mammals. The precise
physiological role of this protein, which is considered to be the fetal form of albumin,
remains to be elucidated. During fetal life it is mainly synthesized by the liver, yolk sac,
and gastrointestinal tract. Increased levels are particularly associated with hepato-
cellular carcinoma, and yolk sac tumors, but can also be observed in certain pancreatic
and gastrointestinal carcinomas, cirrhosis, and acute and chronic hepatitis.7-9 In AT liver
function tests are often (mildly) disturbed, suggesting that the liver is involved in the
disease.
In clinical practice, one must realize that AT may not present the classical phenotype.
As shown by our studies onset at adult age can occur and even cerebellar ataxia is not
always unequivocally present. Ocular telangiectasia may be minimal. Resting tremor
and spinal muscular atrophy may dominate the clinical picture. Immunodeficiency and
radiosensitivity may be close to normal (chapter 3).
The classical phenotype is usually due to large deletions and insertions, splice-site
mutations, and nonsense mutations, all leading to truncation of the ATM protein. Milder
phenotypes have been supposed to be due to missense mutations or small inframe
inserties and deleties.10-13 However, as shown by our report on the Dutch family,
missense mutations also may result in the classical phenotype (chapter 2). 
The occurence of variant AT patients with milder phenotypes can be explained by the
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presence of some rest amount/activity of the ATM protein.12,13 Concerning our patients
displaying only very mild cerebellar ataxia, indeed some rest amount of ATM protein
was found. The activity of the ATM protein by measuring the p53 response was close
to normal (chapter 4). In these patients we identified respectively in patients A1,A2 and
A3 two missense mutations (7622T→G and 3136C→T) , and in patient B a splice site
mutation (IVS21-1G→A) and a missense mutation (8147T→C) (chapter 4). 
The finding of the normal p53 response in our patients (chapter 4) is interesting as it
is in concordance with the presumed neuroprotective role of p53 on cerebellar
development reported in animal model.12-16 It must be stressed, however, that p53
probably is not the sole deteminant for preventing cerebellar degeneration. Abnormal
development of the central nervous system seen in Atm null mice 16, has not been
reported in mouse models for p53 deficiency alone.2 Other ATM dependent proteins
must also play a role. 
Nijmegen breakage syndrome
Nijmegen breakage syndrome as disease entity has been established by our study on
the largest group of NBS patients ever reported (chapter 5). 
NBS appears to be a very rare autosomal recessive multisystem disorder,
characterized by microcephaly with relatively preserved mental development, a typical
facial appearance, immunodefiency, radiation sensitivity, and a predisposition to cancer.
To date, only about 100 patients have been identified in the world (data NBS
Registry). The majority of these patients have an ethnic origin from Eastern Europe,
notably Poland and Czechoslovakia. They harbour a common founder mutation, a 5bp
deletion, 657-661delACAAA, in the responsible gene, NBS1, resulting in production of
a truncated form of the encoding protein nibrin (chapter 5).This mutation does not seem
to be a null mutation allowing some restactivity of the protein. Supportive evidence for
this is found in murine model. Knock out mice are not viable, but mice harbouring the
657-661delACAAA mutation show identical cellular features to those seen in NBS
patients.17,18
Four patients with the NBS phenotype, including the patient described in chapter 8,
have been identified without mutations in NBS1, and with normal levels of nibrin. In
these patients apparently NBS1 is not involved, suggesting another gene, an NBS-like
gene.19
Signs and symptoms may be variable in NBS, but unusual phenotypes with mild
disease manifestations as seen in AT have not been reported, except for one case lacking
microcephaly and displaying congenital heart disease.20 A specific genotype-phenotype
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relation has not been identified (chapter 5). 
Diagnosis of NBS is far from easy. Unlike AT a screening test is not available. The
diagnosis NBS should be considered in case of microcephaly with relatively preserved
mental development and a typical facial appearance with receding forehead, long nose
and receding mandible. A practical work up in case of suspicion of NBS is to perform
immunological and cytogenetic studies. When finding decreased levels of IgA and/or
IgG, and normal levels of IgM, as well as typical rearrangements of chromosomes 7 and
14, additional studies including DNA studies are indicated (chapter 5). As the 657 del
ACAAA mutation is present in approximately 80-90 percent of the patients, genetic
confirmation is relatively simple in most cases.
Microcephaly in Nijmegen breakage syndrome
Our neuropathological study demonstrates that the microcephaly in NBS is not due to
secondary degeneration or necrosis and most probably has a genetic cause. It is
plausible that the gene, NBS1, is involved in the determination of the cortical volume
(chapter 7).
The main finding of the neuropathological analysis of this microcephaly was the
simplified gyral pattern due to reduced tertiary gyri. The number of cortical neurons,
although not quantified, was clearly diminished (chapter 7). 
In normal brain development the formation of tertiary gyri results from the
enlargement of the cortical surface in the available volume of the skull, due to the
increase in the number of neurons and the formation and arborization of dendrites.21
Theoretically, both a reduced number of neurons and a defective arborization may lead
to a simplified gyral pattern. The reduction of cortical neurons may be caused by
impaired neuronal proliferation or uncontrolled apoptosis.21-23
Supportive evidence for a disturbance in proliferation in NBS can be found in animal
studies. In the intrauterine period in mice, NBS1 shows enhanced expression at the level
of telencephalic and diencephalic periventricular matrix zones at the time when
neuronal proliferation takes place there.24 Targeted inactivation of NBS1 leads to early
embryonic lethality and is associated with poorly developed embryonic and
extraembryonic tissues.17,25 These findings suggest that NBS1 mediates essential
functions during proliferation in the absence of external induced damage. A sole
neuronal proliferation defect in NBS patients, however, is unlikely because this cannot
explain why microcephaly in NBS usually occurs late in development, sometimes even
after birth, whereas neuronal proliferation essentially takes place in the first half of
gestation.
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Apoptosis gone awry leading to excessive cell death may also play a role. This
phenomenon has been reported in animal models for several genes implicated in DNA
repair, such as Xrcc4 (X-ray-repair-cross-complementing defective repair in Chinese
hamster mutant 4).26 As yet the phenomenon has not been demonstrated in NBS. The
examined case in our neuropatholgical study was at an age too old for demonstrating
whether apoptosis had taken place in the first months of life.
A defect in arborization cannot be ruled out, but such a defect alone seems very
unlikely as in that case a higher density of remaining neurons than was actually found
would be seen.
In summary, it can be speculated that NBS1 might play a role during the whole period
of corticogenesis. In NBS patients the defective gene might be responsible for
disturbances in proliferation as well as excessive neuronal cell death during cortical
development.
Function of ATM
ATM, the protein defective in AT, is central to the signal transduction process induced
by double strand breaks (DSBs) (Figure 1). ATM orchestrates the respons to this DNA
lesion by phosphorylating numerous substrates, such as p53 and NBS1 (nibrin), which
are involved in cell cycle checkpoint regulation, apoptosis and DNA repair 
(Figure 1).26-36
ATM is supposed to prevent cells themselves from copying thus facilitating DNA
repair, or to induce a p53 dependent apoptosis if the damage is beyond repair. Recently,
in addition to the specific role in DSB response ATM has been proposed to play a role
in maintaining cellular homeostasis. Increasing evidence points to increased oxidative
stress in absence of ATM.36-37
In AT, lacking the supervisory function of ATM, cells can build up somatic mutations,
possibly leading to malignant transformation. The increased propensity for leukemias
and lymphoma in AT may be related to the remarkable number of chromosomal
translocations and inversions in lymphocytes that result from the DNA processing
defect. The defect in DNA repair also explains the sensitivity of cells to ionizing
radiation and radiomimetic chemicals.26-36
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Figure 1. Central role of ATM to the signal transduction process induced by double-strand
breaks.Downstream targets of ATM include p53 and NBS1 (nibrin). NBS1 functions in a complex with the
DNA repair proteins hMRE11 (human meiotic recombination 11) and hRAD50 (human RAD50). ATM can
influence cell cycle progression facilitating DNA repair or make the choice of apoptosis when the damage
is beyond repair (adapted from van Gent DC, 2001, ref.27).
The cell cycle comprises a short stage of cell division, the M phase (mitosis) and a long intervening
interphase. Interphase can be divided into S phase (DNA synthesis), G1 phase (gap between M phase and
S phase) and G2 phase (gap between S phase and M phase).
ATM appears to be involved in the DNA repair mechanism homologous
recombination (Figure 2). This is argumentated by the fact that proteins linked to
homologous recombination, such as RPA (replication protein A) and BRCA1
(breastcancer susceptibility 1), are phosphorylated directly by ATM after ionizing
irradiation. Furthermore meiotic recombination which takes place by homologous
recombination is deficient in ATM-deficient mice.29,30 Last but not least the controlling
role of ATM in homologous recombination has convincibly been shown in chicken
DT40 cells.31
Expression studies in murine models have shown that ATM is expressed in all tissues,
particularly in organs with physiologic DSB repair, such as testis, thymus and spleen,
and in regions of high proliferative activity in brain, liver, kidney and gut.24 Highly
enhanced expression of ATM has been observed during the Purkinje cell neurogenesis
in the area containing Purkinje cell precursors (the ventricular zone of the fourth
ventricle) 24.Perhaps surprisingly, no expression of ATM has been noted in the adult
cerebellum in murine model. The only region of the adult nervous system that exhibited
elevated ATM expression were the postmitotic sensory regions of the dorsal root
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Figure 2. Components of DNA DSB repair pathway: homologous recombination (HR) and non-
homologous endjoining (NHEJ). ATM is supposed to play a role in HR, while NBS1 (nibrin) forming a
complex with hmre11 and hrad50 seems to be involved in both HR and NHEJ.
Abbreviations: hMre11, human meiotic recombination 11; hRad 51, human Rad51; brca1, breast cancer
susceptibility 1; rpa, replication protein A; DNA PKcs, catalytic subunit DNA dependent protein kinase;
XRCC4, X-ray-repair-cross-complementing defective repair in Chinese hamster mutant 4 (adapted from
Gennery et al.,2000 (ref.34), from Khanna and Jackson, 2001 (reference 29), and from Van Gent et al.,
2001 (reference 27))
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Formation of heteroduplex
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ganglia.24
Expression studies of the ataxia telangiectasia gene product in the human central
nervous system, however, did show marked expression of the ATM protein in the
Purkinje cells in the late prenatal and early postnatal period. No expression was found
in the neocortical neurons at these stages.The expression in the Purkinje cells remained
present at a moderate level until the elderly.15 From these expression studies it can be
concluded that ATM seems important for the (early) development and maintenance of
the cerebellum. 
Several reports confirm the presumed maintenance role of ATM in the nervous
system.38-42 In early Purkinje cell neurogenesis p53, which is phosphorylated by ATM,
has been reported to be crucial when mediating radiation induced cell death. In case of
abundant damage, p53 induces apoptosis thus preventing degeneration of cells leading
to dysfunction in later life (39,40). It has been proposed that loss of the p53-dependent
signaling in ATM-deficient neurons in early cerebellar development may allow the
accumulation of genomic damage that in turn may eventually lead to ataxia, as seen in
AT.12,39-40 Thus, ATM seems important to prevent neurodegeneration. 
Function of nibrin
Nibrin (NBS1,p95), the protein defective in NBS, functions in a complex with the
DSB repair proteins hMre11 and hRad 50. The hMre11-hRad50-nibrin complex has
been proposed to act as a sensor of DNA damage. The complex accumulates in nuclear
foci near the site of DSBs and remains at these sites until the damage is repaired.43-49
Nibrin has been linked to both homologous recombination and non-homologous
endjoining.29 The latter is considered the major mechanism for the repair of DSBs in
mammalian cells with key components being the DNA-dependent protein kinase
complex including Ku70, Ku80 and DNA-Pkcs (catalytic subunit DNA dependent
protein kinase), and XRCC4 (X-ray-repair-cross-complementing defective repair in
Chinese hamster mutant 4) and DNA ligase IV 29,48 (Figure 2). Non homologous
endjoining is not only important for the repair of exogenous DNA damage, but also for
the development of the immune system.29
In the absence of nibrin, DNA breaks are not efficiently repaired. This may explain
the immunodeficiency (see also below), radiation sensitivity and increased
susceptibility to cancer in NBS.
Expression studies during mouse development have shown that similar to ATM NBS1
is expressed in all tissues. However, the expression pattern of NBS1 seems to be more
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strictly linked to cellular proliferation than ATM.24 High expression has been observed
in muscle and connective tissue and a time dependent effect is observed.24 These data
suggest a developmental role rather than maintaining role of nibrin. The microcephaly,
facial dysmorphism, and diverse other congenital malformations, frequently observed
in NBS (chapter 5) are in concordance with this hypothesis. Unlike AT in NBS no signs
of (neuro)degeneration have been observed (chapter 5). We have to stress, however, that
most NBS patients do not reach adulthood.
Links between ATM and nibrin
The similarities between AT and NBS, including immunodeficiency accompanied by
recurrent infection, chromosomal instability, radiation hypersensitivity, and
predispostion to cancer strongly suggest functional links between ATM and nibrin.
Several reports confirm these links.50-54
Interesting in this respect is the ataxia-telangiectasia like disorder (ATLD), which has
been identified in only a small number of individuals. Affected patients show
progressive ataxia without telangiectasia. The overall neurologic phenotype is similar
to that of AT. ATLD patients disclose mutations in the hMRE11 gene not in the ATM
gene. The cellular features resulting from these hMRE11 mutations reflect those seen in
AT as well as NBS and include hypersensitivity to ionizing irradiation and radio-
resistant DNA synthesis.53 These overlaps between AT, ATLD and NBS strongly
suggests that ATM and the nibrin-hMRE11-hRad50 complex function in the same
biological pathway. 
Futher evidence of a link between these proteins has come from the findings that
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Figure 3.  Hypothesis of the function of ATM and nibrin in the central nervous system.
Maintenance
Development
ATM Nibrin
DSBs stimulate ATM to phosphorylate nibrin and that this phosphorylation is required
for cells to tolerate IR-induced damage and to slow DNA synthesis. 
This emphasizes that ATM has a role not only in preventing cells from propagating
damaged DNA, but also (through nibrin) in the processing and repair of DSBs 
(Figures 1,2).50-54
It should be noted, however, that the phosphorylation of the tumour suppressor
protein p53 by ATM is not altered by loss of nibrin and hMRE11, whereas this is
seriously disturbed by ATM loss.50 This distinction is consistent with the idea that p53
functions are not critical to the common cellular pathologies associated with these
syndromes, especially immunodeficiency and predisposition to lymphoreticular
malignancies. These features are probably mainly the result of chromosomal
aberrations, due to inappropriate recombination or repair of DSBs.
Role of nibrin and ATM in the immune system
Because development of the immune system relies on recombination, one might
predict that genes that function in recombination and/or repair, when mutated, may
cause immunodefiency.34,55-57 It is therefore not surprising that several immuno-
defiencies have been correlated with enzymes essential to recombination/repair. An
example is radiosensitive severe combined immunodefiency (RS-SCID), a disorder
that, as recently has been shown, may be caused by mutations in the Artemis gene . This
gene encodes a protein that is involved in V(D)J recombination/ non-homologous end-
joining.56-57
In NBS we found a discrepancy between relatively normal IgM concentrations and
decreased both IgG and IgA concentrations (chapter 6). We supposed this to be due to
a defect in immunoglobulin class switch recombination, and suggested a role of the
defective gene, NBS1 (chapter 6).
Recently it has been reported that the NBS1 gene product, nibrin, is involved in V(D)J
recombination and class switch recombination.58,59
V(D)J recombination is the site-specific process of recombination that occurs in B-
cells to generate variable regions of immunoglobulin molecules or, in T cells, to create
the variable regions of the antigen receptor. V(D)J recombination is initiated by a pair
of proteins, recombination activating gene 1 (RAG1) and recombination activating gene
2 (RAG2), which are produced only in lymphocytes. These RAG proteins introduce
DSBs precisely between immunoglobulin and T cell receptor (TCR) coding gene
segments and flanking recombination signal sequences. After cleavage the broken DNA
intermediates are sequestered from the DNA damage surveillance machinery and the
-132-
General discussion and future perspectives
ends are then sealed in a reaction that depends on ubiquitous factors involved in non-
homologous endjoining,such as Ku70,Ku80,DNA-PKcs,DNAligase IV, and XRCC4. It
has been demonstrated that the hMre11/Rad50/NBS1 complex and histone γ-H2AX,
another DNA damage sensor, are found at sites of V(D)J recombination induced DSBs.
They form nuclear foci that colocalize with the T cell receptor α- locus in response to
RAG mediated V)D)J cleavage.58
Class switch recombination occurs later in B-cell development. It is a regulated
process of DNA deletion (Figure 4). It is a region-specific DNA recombination that
replaces one immunoglobulin heavy chain constant region (Ch gene) with another. This
enables a single variable (V)region to be used in conjunction with different Ch genes,
each having a unique biological activity. In this process, components of the non-
homologous endjoining pathway for repair of DSBs also play a role. 
It has been shown that in class switch recombination, hMre11/Rad50/nibrin and γ-
H2AX play a role as well. They form nuclear foci at the Ch region in the G1 phase of
the cell cycle.59 Furthermore it was demonstrated that this process requires the RNA-
editing enzyme activation-induced cytidine deaminase (AID).57 These data confirm
involvement of nibrin in the development of the immune system. They suggest that, in
cellular immunity nibrin is involved in the development of the T cell receptor and in
humoral immunity, in class switch recombination. This may explain the CD4+ and
CD3+ deficiencies as well as the deficiencies of IgG and IgA in NBS.
In AT identical immunological disturbances as noted in NBS are present.34 It is
plausible that due to a disturbed phosphorylation of nibrin (see links between ATM and
nibrin) by defective ATM the same mechanism is disturbed. 
Future perspectives
Clinical and genetic studies
Based on the presented data we suggest to perform further studies on the following
issues: genotype-phenotype relation, neurodegeneration in NBS, and spinal muscular
atrophy of undetermined cause.
genotype-phenotype relation 
It remains worthwhile to identify variant AT patients displaying milder phenotypes.
These variant AT patients usually show some residual ATM activity. Studying the
clinical features in correlation to the ATM activity can increase the insight in the
functions of ATM. This also applies to NBS, but it must be stressed that variant NBS
patients are thought to be extremely rare. 
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neurodegeneration in NBS
In contrast to AT in NBS no signs of neurodegeneration have been reported. This
remains intriguing as ATM and NBS1 interact and mutations in hMre11, which is
closely related to NBS1, may lead to ATLD (see links between ATM and nibrin). 
To investigate signs of neurodegeneration it would be of interest to perform
neurological and psychometric studies in NBS patients at older age. It must be stressed,
however, that long time survival is exceptional in NBS. 
spinal muscular atrophy of undetermined cause 
In AT, spinal muscular atrophy is common, usually occuring beyond adolescence, and
it may even predominate the clinical picture (chapter 4). Because of this, one may
speculate that the gene responsible for AT, ATM, might also be involved in some
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Figure 4 .Class switch recombination in mouse model. Initially, B cells transcribe a VDJ gene and a µ
heavy chain that is spliced to produce mRNA for IgM. Class switching may occur, illustrated here as a
switch from IgM to IgA. Recombination between two regions takes places with the loss of the intervening
C genes, in this case Cµ, Cδ, Cγ3, Cγ1, cγ2b, Cγ2a and Cε. The hMre11/hRad50/NBS1 complex is
involved in this process. 
cases of adult onset spinal muscular atrophy that are not due to the SMN gene defects.
Theoretically, some of these patients can be genuine AT patients displaying a milder
phenotype, or perhaps they are AT heterozygotes. Current knowledge is that AT
heterozygotes do not display clinical features of AT but do have a greater breast cancer
risk than normal individuals. Along the same lines we speculate that AT heterozygosity
predisposes to spinal muscular atrophy. As far as we know no data are available on the
occurence of spinal muscular atrophy in AT heterozygotes. Therefore to test our
hypothesis we would like to determine alphafetoprotein levels in unresolved cases of
spinal muscular atrophy, and to screen for ATM mutations. 
Therapy
At the moment no therapy for AT or NBS exists. Specific therapeutic strategies may
follow when pathophysiological mechanisms have been resolved. 
Potential therapies include dietary interventions with key micronutrients required for
DNA maintenance and anti-apoptosis drugs.
Dietary interventions
Experimental treatment with vitamin B12 and folic acid is an option, as these seem to
be required for genomic stability. Both in vitro and in vivo studies with human cells
have clearly shown that vitamin B12 deficiency, folate deficiency, and elevated plasma
homocysteine are associated with expression of chromosomal fragile sites,
chromosome breaks, excessive uracil in DNA, micronucleus formation and DNA
hypomethylation.59,60 Intervention studies have demonstrated that these DNA lesions
can be minimised when high plasma concentrations of folate and/or vitamin B12 are
achieved.60-62
Anti-apoptosis drugs
Theoretically anti-apoptosis drugs may be of interest as in AT, and perhaps also in
NBS, abundant apoptotic cell death plays a role. Particularly, concerning the spinal
muscular atrophy which develops in the course of AT, treatment with riluzole should be
considered. This product has been shown to be beneficial in amyotrophic lateral
sclerosis, a disorder in which apoptosis also plays a role.63
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Summary
This thesis describes neurological, immunological, and genetic aspects of the DNA
repair disorders ataxia telangiectasia (AT) and Nijmegen breakage syndrome (NBS).
The chapters 1-4 deal with ataxia telangiectasia and the chapters 5-8 with Nijmegen
breakage syndrome. 
In chapter 1 the classical picture of ataxia telangiectasia is described. An overview is
given of the knowledge on AT up to end 2003. An illustrative case is presented and
clinical and laboratory features are described extensively.
Chapter 2 deals with a new double missense mutation in the ataxia telangiectasia
gene in a Dutch family (brother and sister). This homozygous mutation consists of two
consecutive base substitutions in exon 55: a T→G transversion at position 7875 of the
ATM cDNA and a G→C transversion at position 7876.
The double base substitution results in an amino acid change of an aspartic acid to a
glutamic acid at codon 2626 of the ATM protein.
It is discussed that the mutation probably is a disease-causing mutation.
In chapter 3 two young adult brothers are described who were diagnosed with AT but
in whom cerebellar ataxia was not unequivocally present. Their most striking symptom
was a resting tremor. In one of the brothers MRI showed slight caudate atrophy and a
decreased cerebrospinal fluid homovanillic acid (HVA) level, both findings suggestive
for an extrapyramidal origin of the resting tremor.
The report dates from 1994. The diagnosis AT was based on the presence of an
increased alphafetoprotein concentration and typical rearrangements of chromosomes 7
and 14. Genetic confirmation at that time was not possible yet.
In chapter 4 four adult onset AT patients are described lacking pronounced cerebellar
atrophy but displaying severe spinal muscular atrophy of the lower extremities. The
patients are 3 brothers and an unrelated female case. They presented with resting tremor
at young adult age, an aspect that has been previously described in two of the three
brothers (see chapter 3). 
The diagnosis spinal muscular atrophy was based on: (1) atrophy and weakness,
(2) normal to borderline delayed motor conduction velocities with markedly decreased
compound muscle action potentials, (3) denervation activity in both quadriceps and
anterior tibial muscle, and (4) neurogenic changes in muscle biopsy.
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The diagnosis AT was confirmed by genetic studies showing ATM mutations on both
alleles: two missense mutations (7622 T→G and 3136 C→T) in the three brothers, and
a splice site mutation (IVS21-1G→A) and a missense muation (8147T→C) in the
female case. The ATM protein level was reduced. The ATM function, as measured by
the p53 respons, however, was close to normal. 
The role of the ATM/p53 function in the nervous system is discussed. As p53 is
considered to be neuroprotective the finding of a nearly normal p53 response is in
concordance with the only mild cerebellar ataxia, but evidently not with the severe
spinal muscualar atrophy. Apparently concerning the anterior horn cells p53 is not the
only factor in preventing neural damage.
In chapter 5 the clinical and laboratory features in 55 NBS patients are described as
wel as the genotype-phenotype relation. Essential features found in NBS were
microcephaly, usually without severe mental retardation, typical facial appearance,
immunodeficiency, chromosomal instability, X-ray hypersensitivity, and predisposition
to cancer. Important additional features were skin abnormalities and congenital
malformations. No specific genotype-phenotype relation could be found. Specific
mutations did not lead to specific clinical features. This study gives an overview of the
knowledge on NBS up to 2000. 
In chapter 6 an immunological study in NBS is described.
The development of the immune system relies on recombination, which involves repair
of DNA breaks. Therefore one might predict that mutations in NBS1 could cause
immunodeficiency.
In the study the world’s largest series of NBS patients were investigated.
Immunodeficiency was confirmed. IgA, IgG and IgG2 levels were decreased in most
patients, while IgM levels were normal or even slightly increased. The data are
compatible with a defective class switching in NBS. A role of the NBS1 protein in this
process is suggested.
Chapter 7 deals with a neuropathological study in NBS. The neuropathological
findings of the first recognised case of NBS are reported.The patient showed severe
microcephaly with simplified gyral pattern especially in the frontal lobes. There were
no signs of a degenerative disease or of a primary migration disorder. The number of
cortical neurons, although not quantified, was clearly diminished. It is discussed that the
microcephaly in NBS most probably has a genetic cause. A role for the NBS1 gene in
corticogenesis in man is suggested.
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In chapter 8 a patient with the NBS phenotype is described. The patient had deafness
unlike all the other patients reported so far. Mutation detection did not show a mutation
in NBS1 and the protein nibrin was normally expressed. The presence of another gene,
a NBS-like gene, is suggested. 
In the general discussion the main findings of the studies described in the chapters are
evaluated in the context of the current knowledge on AT and NBS.
The specific roles of ATM and nibrin and their interactions are described. The distinct
neurological features of AT and NBS are likely to be due to different roles of ATM and
nibrin in the nervous system. Nibrin seems to be particularly important for the
development of the nervous system, while ATM seems to play a more maintaining role. 
The similarities on the laboratory level between the two disorders seem to be the result
of functional links between the two proteins.
-144-
Summary
-145-
Samenvatting
C
C
T
G C
T A
G C
A T
C G
C G
A
G C
A T
G C
T
A
G C
T A
G
A T
G
Samenvatting
In dit proefschrift worden enkele neurologische, immunologische en genetische
aspecten beschreven van de ziektebeelden ataxia telangiectasia (AT) en Nijmegen breuk
syndroom (NBS).
Ataxia telangiectasia en Nijmegen breuk syndroom zijn aandoeningen veroorzaakt
door een stoornis in het DNA-reparatiemechanisme (DNA repair).  
Alvorens nader in te gaan op de twee ziektebeelden AT en NBS en de onderzoeks-
bevindingen, wordt eerst een korte uiteenzetting  gegeven over DNA-structuur, DNA-
dubbelstrengsbreuken met herstelmechanismen en DNA-reparatieziekten (DNA repair
ziekten).    
DNA structuur
DNA, desoxyribonucleinezuur, is een lineair polymeer macromolecuul. Het heeft een
dubbele helixstructuur van twee polynucleotideketens. Een nucleotide bestaat uit een
purine- of pyrimidinebase (stikstofbase), een pentosesuiker en een fosfaatgroep. De
belangrijkste eigenschap van de dubbele helix is de specifieke paring van de basen. Er
zijn slechts twee complementaire baseparen: A-T (adenine-thymine) en G-C (guanine-
cytosine). Het DNA bevat de genetische code voor de eiwitten, de belangrijkste
bouwstenen van de cel. Eiwitketens bestaan uit variabele ketens, die zijn opgebouwd
uit twintig verschillende aminozuren. Het totale aantal en de volgorde van de
aminozuren bepalen de karakteristiek van het eiwit. Een combinatie van drie
opeenvolgende nucleotiden (triplet of codon) herbergt de code voor een aminozuur. 
Het DNA, en dus de daarin aanwezige informatie, bevindt zich in de kern van de cel,
een klein gedeelte ook in het mitochondrion van de cel. De eigenlijke aanmaak van de
eiwitten vindt echter hoofdzakelijk plaats in het cytoplasma van de cel. Er moet dus
overdracht en transport van DNA-informatie plaatsvinden. Dit gebeurt via vorming van
RNA, ribonucleinezuur. RNA onderscheidt zich van DNA door een andere suikergroep
en iets andere basensamenstelling (U, uracil, in plaats van T). Er zijn drie soorten RNA:
rRNA (=ribosomaal RNA), tRNA(=transport RNA) en mRNA (=messenger RNA). De
eerste twee hebben geen coderende functie maar een procesondersteunende functie. Het
mRNA fungeert als boodschapper voor de overdracht van de genetische informatie naar
de ribosomen, waar de eiwitsynthese plaatsvindt. 
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DNA dubbelstrengsbreuken (DSBs) en herstelmechanismen 
Beschadiging van het DNA kan zowel door exogene als door endogene oorzaken
ontstaan. Voorbeelden van exogene oorzaken zijn blootstelling aan ioniserende straling
en chemische stoffen. Endogene oorzaken kunnen zijn de aanwezigheid van vrije
zuurstofradicalen en resten van koolwaterstofverbindingen, producten die ontstaan als
bijproducten van de normale stofwisseling.
Van de diverse vormen van DNA-schade wordt de DNA-dubbelstrengsbreuk (DSB)
beschouwd als een van de meest gevaarlijke. Een dergelijke breuk kan betekenen dat
een gen wegvalt of dat de controle over een gen wegvalt. Dit heeft als gevolg de
instabiliteit van het genoom met degeneratie van cellen of celdood.   
DNA-dubbelstrengsbreuken zijn vaak het gevolg van straling en chemotoxines. Ze
vormen echter ook een onderdeel van fysiologische processen, zoals bij de meiosis voor
het initiëren van recombinatie (voor de genetische variatie van de geslachtscellen) en
bij de vorming van het immuunsysteem voor de formatie van het uitgebreide repertoire
aan B- en T-cel antigeen receptoren. Bij dit laatste proces worden wisselend
combinaties van gensegmenten gemaakt via DNA- herschikkingsprocessen(V(D)J =
variable division joining).
DNA-dubbelstrengsbreuken kunnen op twee manieren worden hersteld: door
homologe recombinatie en door niet-homologe eindverbinding. Bij deze mechanismen
zijn talrijke DNA- reparatie-enzymen betrokken. Bij de homologe recombinatie wordt
een overeenkomstig chromosoom gebruikt als een matrijs om de schade te herstellen.
Bij niet-homologe eindverbinding worden de brokstukken simpelweg aan elkaar
bevestigd. Homologe recombinatie is een zeer precies herstelmechanisme,
vergelijkbaar met een legpuzzel waarbij de stukjes exact op de plaats vallen. Niet-
homologe eindverbinding is een veel grovere methode waarbij gemakkelijk fouten
kunnen optreden. De meeste van deze fouten zijn echter onschuldig. Algemeen wordt
aangenomen dat bij zoogdieren, inclusief de mens, DNA-dubbelstrengsbreuken
overwegend worden gerepareerd door niet-homologe eindverbinding. Bij de vorming
van de geslachtscellen worden tijdens de cross-over vele stukjes DNA geknipt en weer
hersteld. Dit herstel verloopt door homologe recombinatie. Dit is begrijpelijk aangezien
bij dit proces geen fouten geoorloofd zijn.  
DNA-reparatie ziekten (DNA repair ziekten)
De laatste jaren staat DNA-reparatie (DNA repair) erg in de belangstelling. Over de
manier waarop cellen hun DNA repareren is steeds meer bekend geworden. Tot
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dusverre zijn al meer dan 125 genen geïdentificeerd die betrokken zijn bij DNA repair. 
Het mechanisme van DNA repair wordt gewoonlijk geassocieerd met oncologische
aandoeningen, aangezien begrijpelijk is dat  stoornissen in DNA repair kunnen leiden
tot kanker. Veel minder bekend is dat het mechanisme ook een rol kan spelen bij
neurologische aandoeningen. Er zijn steeds meer aanwijzingen dat DNA repair
betrokken is bij het ontwikkelen en instandhouden van het zenuwstelsel. In dit
proefschrift wordt hier nader op ingegaan. 
Voorbeelden van ziekten die geassocieerd worden met genetische defecten in DNA
repair, de zogeheten DNA repair ziekten, zijn: Bloom syndroom, xeroderma
pigmentosa, Fanconi anemie, ataxia telangiectasia, Nijmegen breuksyndroom,
Cockayne syndroom en Werner syndroom. Deze aandoeningen vertonen klinische en
celbiologische overeenkomsten, maar zijn genetisch verschillend.
Twee DNA repair ziekten die duidelijke neurologische verschijnselen vertonen zijn
ataxia telangiectasia en Nijmegen breuksyndroom. Deze ziektebeelden zijn daarom
gekozen als onderwerp van dit proefschrift. 
Ataxia telangiectasia (AT)
Ataxia telangiectasia (AT), ook wel Louis-Bar syndroom genoemd, is een zeldzame
autosomaal recessieve multisysteem aandoening, die zich gewoonlijk openbaart
rondom het tweede levensjaar. De ziekte wordt gekarakteriseerd door een progressieve
cerebellaire ataxia, oculocutane telangiectasieën, verhoogd serum alphafoetoproteine,
immuundeficiëntie verhoogde gevoeligheid voor ioniserende straling, chromosomale
instabiliteit (met name chromosoom 7 en 14) en predispositie voor kanker.
Naast cerebellaire ataxie komen ook andere neurologische verschijnselen voor, met
name choreoathetose, oculomotore dyspraxie, polyneuropathie en spinale spieratrofie.
Het gen dat verantwoordelijk is voor AT, namelijk ATM (ATmutated), is gelegen op
chromosoom 11q22-23 en codeert voor het eiwit ATM kinase (ATM). Wereldwijd zijn
al meer dan 300 verschillende ziekteveroorzakende mutaties geïdentificeerd. 
De ziekte komt voor bij alle rassen en op alle continenten. De incidentie wordt
geschat op 1 op de 40.000-80.000 geboorten. Ongeveer 0,5-1% van de wereldbevolking
is drager van de ziekte. Momenteel zijn in Nederland 27 families bekend met AT.
Er is tot op heden geen curatieve therapie voor AT. Alle therapie is symptomatisch.
De meeste patiënten overlijden tussen het 20e en 30e levensjaar door chronische
infecties en/of maligniteit (hoofdstuk 1).
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Functie van ATM-kinase
ATM-kinase of kortweg ATM, het defecte eiwit bij de ziekte AT, is verwant aan de
Pl3-kinases. Pl3-kinases zijn betrokken bij de controle van de celcyclus en het in stand
houden van het genoom.
ATM speelt een centrale rol bij het signaaltransductieproces geïnduceerd door DNA-
dubbelstrengsbreuken en regisseert een responsmechanisme via diverse 'downstream'
eiwitten, die betrokken zijn bij cel cyclus checkpoint regulering, apoptosis en DNA
repair. Belangrijke 'downstream' eiwitten zijn het tumor suppressor eiwit p53, het
checkpoint protein kinase Chk2, het borstkanker genproduct Brca1 en het Nijmegen
breuk syndroom genproduct NBS1 (nibrin). De laatste functioneert in een complex met
de DNA repair eiwitten human meiotic recombination11 (hMre11) en human Rad50
(hRad50). Er zijn steeds meer aanwijzingen dat ATM betrokken is bij het DNA repair
mechanisme homologe recombinatie.  
In muizenmodel blijkt ATM in alle weefsels tot expressie te komen, met name in
regio's met hoge proliferatieve activiteit zoals thymus en milt. Van het genproduct ATM
is aangetoond dat dit in het zenuwstelsel van de mens met name tot expressie komt in
de Purkinjecellen. De expressie is het meest uitgesproken in de late prenatale periode
en vroege postnatale periode. Daarna neemt de expressie wat af, maar blijft
nadrukkelijk aanwezig tot op oudere leeftijd. Dit suggereert een belangrijke rol voor
ATM bij de ontwikkeling en vooral het instandhouden van het cerebellum.
Het eiwit bevindt zich voornamelijk in de kern van de cel, maar wordt ook
waargenomen in het cytoplasma.
In normale cellen zal DNA-schade aanleiding geven tot vertraging of stilzetten van
de DNA-synthese met als gevolg facilitering van DNA-herstel. In geval van overmatige
schade zal de keuze echter worden gemaakt voor inductie van apoptosis
(geprogrammeerde celdood), waardoor voorkomen wordt dat gedegenereerde cellen
overleven. ATM speelt dus een belangrijke rol bij de keuze tussen overleven door DNA
repair en terminatie door apoptosis. Deficiëntie van ATM-kinase verstoort dit normale
mechanisme waardoor ernstige ontregelingen kunnen worden verwacht, met name in
weefsels met hoge proliferatieve capaciteit. In dat kader zijn immuundeficiëntie en
predispositie voor kanker bij AT goed voorstelbaar. Ook goed te begrijpen is dat
postmitotische cellen, zoals neuronen, in het centrale zenuwstelsel meer kwetsbaar zijn
in geval van disfunctionerende repair mechanismen. Het is echter nog steeds
onduidelijk waarom met name Purkinjecellen van het cerebellum en voorhoorncellen in
het ruggenmerg specifiek zijn aangedaan bij AT (hoofdstuk 1). 
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Klassiek en variant phenotype
In de algemene klinische praktijk is het belangrijk om te realiseren dat AT niet altijd
het klassieke phenotype vertoont. Zoals we hebben aangetoond bij vier patiënten, drie
broers en een niet verwante vrouwelijke patiënt, kan de ziekte zich ook pas presenteren
op volwassen leeftijd en is zelfs cerebellaire ataxie niet altijd manifest aanwezig.
Oculaire telangiectasieën kunnen weinig uitgesproken zijn. Een rusttremor en spinale
spieratrofie kunnen het beeld domineren. Immuniteit en stralengevoeligheid kunnen
vrijwel normaal zijn (hoofdstuk 3 en 4).
Het klassieke fenotype van AT is gewoonlijk het gevolg van grote deleties en
inserties, splice-site mutaties en nonsense mutaties die leiden tot volledige ontregeling
en inactivering van de eiwitstructuur. Mildere phenotypes worden meestal
toegeschreven aan missense mutaties of kleine inframe inserties en deleties. Echter,
zoals we hebben aangetoond bij een Nederlandse familie (broer en zus), kunnen
missense mutaties zeker ook resulteren in het klassieke phenotype (hoofdstuk 2). 
Het voorkomen van variant AT-patiënten met mildere phenotypes, kan worden
verklaard door enige resthoeveelheid/activiteit van het ATM-eiwit. Bij onze vier
patiënten, die nauwelijks cerebellaire verschijnselen vertoonden, werd inderdaad enige
resthoeveelheid van het ATM-eiwit gevonden. De activiteit van het eiwit gemeten aan
de p53 response was vrijwel normaal. De patiënten bleken compound heterozygoten.
De drie broers hadden twee missense mutaties, de vrouwelijke patiënt had een missense
mutatie en daarnaast een splice-site mutatie (hoofdstuk 4).
De bevinding van de normale p53 respons in de genoemde patiënten is interessant
aangezien dit in overeenstemming is met de veronderstelde neuroprotectieve rol van
p53 betreffende het cerebellum, zoals gerapporteerd in dierstudies (hoofdstuk 4). 
Diagnostiek
Als AT wordt vermoed, verdient het sterke aanbeveling alfafoetoproteïne in het bloed
te bepalen. Het vinden van een verhoogde waarde van minimaal twee
standaarddeviaties boven het gemiddelde bij patiënten ouder dan 8 maanden is vrijwel
pathognomonisch voor de ziekte (hoofdstuk 1). Bij het vinden van een verhoogd
alphafoetoproteine zijn additionele onderzoekingen in de zin van immunologische en
cytogenetische studies geïndiceerd De diagnose kan worden bevestigd door DNA-
studies.
-150-
Samenvatting
Nijmegen breuk syndroom
Nijmegen breuk syndroom is een zeer zeldzame ziekte, gekenmerkt door
microcephalie met relatief behouden intelligentie, een typisch aangezicht met wat
terugwijkend voorhoofd, lange neus en terugwijkende onderkin. Andere kenmerken
zijn immuundeficiëntie chromosomale instabiliteit (met name van chromosoom 7 en
14), stralengevoeligheid en sterk verhoogde gevoeligheid voor kanker. Daarnaast
worden bij de aandoening frequent huidafwijkingen gezien, met name café au lait
vlekken en vitiligo. Andere afwijkingen die worden gezien zijn diverse congenitale
malformaties, vooral clinodactylie en syndactylie. 
De ziekte is vernoemd naar de plaats Nijmegen omdat daar de eerste patiënt werd
beschreven (Weemaes et al., Acta Paediatr Scand 1981). NBS is lange tijd beschouwd
als een variant van ataxia telangiectasia vanwege sterke overeenkomsten op
celbiologisch nivo. Het genetisch defect bleek echter totaal verschillend. Het gen,
NBS1, is gelegen op chromosoom 8q21 en codeert voor het eiwit nibrin.
Op dit moment zijn in de wereld ongeveer 100 patiënten geïdentificeerd. De gegevens
van deze patiënten worden bijgehouden in het NBS-register te Nijmegen. De meeste
patiënten zijn afkomstig uit Oost-Europa, met name uit Polen (hoofdstuk 5). Het
merendeel van de patiënten heeft als mutatie een 5bp deletie, 657-661delACAAA.
Deze mutatie heeft een duidelijk 'founder'-effect, gezien het frequent voorkomen in een
geografisch verwante populatie (hoofdstuk 5).     
Aangezien uit dierstudies is gebleken dat NBS1 knock out muizen niet levensvatbaar
zijn, lijkt het waarschijnlijk dat de beschreven NBS1 mutaties bij de mens geen
nulmutaties zijn en er nog enige restactiviteit van het eiwit aanwezig is (hoofdstuk 6).
In de literatuur zijn vier patiënten met het NBS phenotype gerapporteerd (waaronder
de patiënt in hoofdstuk 8), bij wie geen NBS1 mutatie is geïdentificeerd en sprake is
van een normale expressie van het eiwit nibrin. Bij deze patiënten is NBS1 dus blijkbaar
niet betrokken. Een en ander is zeer suggestief voor de aanwezigheid van een ander gen,
een 'NBS1-like' gen.      
Er is geen curatieve therapie voor NBS. Elke vorm van therapie is ondersteunend. De
meeste patiënten overlijden op kinderleeftijd aan een infectie of maligniteit.  
Functie van nibrin 
Nibrin, ook wel NBS1 of p95 genoemd, functioneert in een complex met de DNA
repair eiwitten hMRe11 en hRad50. Het complex werkt waarschijnlijk als een soort
sensor van DNA-schade en speelt een rol bij herstel. Het is aangetoond dat het complex
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zich nestelt bij DSBs en daar blijft tot de breuken zijn hersteld. 
Nibrin is betrokken bij de DNA-reparatiemechanismen niet-homologe eindver-
binding en homologe recombinatie.
In de afwezigheid van nibrin worden DNA-breuken niet efficiënt gerepareerd. Dit is
een verklaring voor de immuundeficiëntie, stralengevoeligheid en verhoogde
gevoeligheid voor kanker in NBS.
Het expressiepatroon van het gen NBS1 is bestudeerd bij muizen en heeft aangetoond
dat NBS1 evenals ATM tot expressie komt in alle weefsels, maar dat deze expressie
vooral uitgesproken is tijdens de cellulaire proliferatiefase. Dit suggereert dat
NBS1/nibrin vooral een rol speelt in de (vroege) ontwikkeling. De microcephalie,
faciale dysmorfie en diverse andere congenitale malformaties zijn compatibel met deze
hypothese. 
Betreffende de microcephalie wordt de mogelijke rol van NBS1 in de corticogenese
ondersteund door onze neuropathologische studie van de eerstbeschreven NBS patiënt
(patiënt 1 in het NBS register). Er werden bij de neuropathologische analyse geen
aanwijzingen gevonden voor secundaire degeneratie of necrose, wat een genetische
oorzaak voor de microcephalie zeer aannemelijk maakt. De belangrijkste bevinding was
een vereenvoudigd gyraal patroon ten gevolge van een verminderd aantal tertiare gyri.
Het aantal neuronen was duidelijk verminderd. Een en ander kan zeer wel samenhangen
met een stoornis in de proliferatie en/of ongecontroleerde apoptosis, zoals reeds is
aangetoond bij diverse andere DNA repair genen (hoofdstuk 7).
Voorts zijn er aanwijzingen dat nibrin een belangrijke rol speelt bij de ontwikkeling
van het immuunsysteem. Bij de ontwikkeling van het immuunsysteem (cellulair en
humoraal) is sprake van V(D)J-recombinatie (zie eerder). V(D)J-recombinatie wordt bij
de verdere ontwikkeling van de immuunglobulines gevolgd door class switch
recombinatie. Class switch recombinatie is een gereguleerd proces van DNA deletie
(waarbij bijvoorbeeld 'geswitched' wordt van IgM naar IgA of van IgM naar IgG). Het
is aangetoond dat het hMre11/hrad50/nibrin complex en histone γ-H2AX, een andere
sensor van DNA schade, zich nestelen in de buurt van DSBs geïnduceerd door V(D)J
recombinatie, waarbij ze zich richten op de T-cel receptor locus.  
Bij class switch recombinatie spelen het hMre11/hrad50/nibrin complex en histone 
γ-H2AX ook een rol. Ze vormen foci bij de Ch-regio (immunoglobulin heavy chain
constant region). Deze gegevens suggereren dat betreffende de cellulaire immuniteit
nibrin betrokken is bij de ontwikkeling van de T-cell receptor en betreffende de
humorale immuniteit bij class switching. Bij Nijmegen breuk syndroom is dit
mechanisme verstoord, hetgeen de aanwezigheid van deficiënties van CD4+ en CD3+
cellen, alsook die van IgA en IgG (bij normaal IgM) kan verklaren (zie ook hoofd-
stuk 6).     
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Variant fenotype 
Symptomen en verschijnselen bij NBS kunnen variabel zijn. Atypisch fenotypes met
milde klinische verschijnselen zoals bij ataxia telangiectasia, zijn niet beschreven,
behoudens één patiënt. Deze patiënt met een NBS1 mutatie heeft merkwaardigerwijze
geen microcephalie maar wel een congenitale hartziekte.  
Een duidelijke genotype-phenotype relatie is niet aanwezig bij NBS (hoofdstuk 5).
Diagnostiek
De diagnostiek van Nijmegen breuksyndroom is verre van eenvoudig. In tegenstelling
tot AT is er geen screeningstest beschikbaar. De diagnose moet worden overwogen als
er sprake is  van microcephalie met relatief intacte intelligentie en een typisch gelaat
met terugwijkend voorhoofd, lange neus en terugwijkende onderkin. Een praktische
aanpak bij verdenking op NBS is het verrichten van immunologische en cytogenetische
studies. Indien IgA en/of IgG deficiëntie en afwijkingen van chromosoom 7 en 14
(inversies en translocaties) worden gevonden, zijn DNA studies geïndiceerd (hoofd-
stuk 5).    
Ataxia telangiectasia en Nijmegen breuksyndroom: functionele
verbindingen tussen ATM en nibrin 
De overeenkomsten tussen AT en NBS, zoals immuundeficiëntie, stralengevoeligheid
en predispositie voor kanker, suggereren sterk het bestaan van functionele verbindingen
tussen ATM en nibrin.  
Diverse onderzoeken hebben dit ook aangetoond. Zo is gebleken dat bij DSBs het
hMre11/hRad50/nibrin complex wordt geactiveerd door ATM en dat deze activatie
nodig is voor de cellen om hun DNA-synthese af te remmen en DNA-herstel te laten
plaatsvinden.
Interessant in dit kader en ook sterk ondersteunend voor de aanname dat ATM en het
nibrin/hMRE11/hRad50 complex in een zelfde pathway functioneren, is de op ataxia
telangiectasia- gelijkende ziekte (ataxia telangiectasia-like disorder, ATLD).
Bij deze aandoening is, net zoals bij AT, sprake van een progressieve ataxie, doch
ontbreken telangiectasieën. De cellulaire verschijnselen zijn zoals die gevonden worden
bij AT en NBS. Het genetisch defect is echter geen mutatie in het ATM gen, maar in het
hMre11 gen.  
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Dankwoord
Het in dit proefschrift vermelde onderzoek werd gecoördineerd vanuit het Instituut
voor Neurologie en de Afdeling Kindergeneeskunde van het UMC St. Radboud te
Nijmegen. Het onderzoek is steeds sterk multidisciplinair van karakter geweest.
Diverse collega’s uit binnen- en buitenland hebben  geparticipeerd en belangrijke
bijdragen geleverd.
Graag wil ik op deze plaats iedereen die aan de totstandkoming van het proefschrift
heeft bijgedragen bedanken.
Een aantal personen die mijn insziens een sleutelrol hebben gespeeld wil ik met name
noemen. 
Dr. C.M.R. Weemaes. Beste Corry, jij vervult al jaren een belangrijke rol in het
internationale AT en NBS onderzoek. Zonder jou was dit proefschrift niet van de grond
gekomen. Je  hebt me steeds met raad en daad gesteund en me ook op sleeptouw
genomen naar de diverse AT/NBS workshops. Nooit was je iets teveel. Toen mijn
automobiel richting Nijmegen een keer strandde, was je niet te beroerd om de volgende
dag gewoon naar Brabant af te reizen om bij mij thuis de zaken uit te werken. Ik ben je
daar zeer erkentelijk voor.
Prof.dr. F.J.M. Gabreëls. Beste Fons, jij bent voor mij steeds de grote motivator en
inspirator van het onderzoek geweest. Jij hebt de zeldzame eigenschap te beschikken
over een helicopter view en een zeer sterk analytisch vermogen. Bij het toch vaak
basaal onderzoek heb je nooit uit het oog verloren dat de primaire insteek voor mij als
neuroloog de klinische neurologie moest zijn. 
Je gastvrijheid heb ik zeer gewaardeerd. Na elke vergadering bij jou thuis voelde ik
me weer gesterkt om het karwei voort te zetten.
Prof.dr. B.G.M. van Engelen. Beste Baziel, jij bent voor mij een soort architect
geweest. Je weet als geen ander creatieve ideeën in een concreet concept te gieten. Jij
hebt me fantastisch geholpen met “de bouw” van het proefschrift. Veel dank daarvoor.
Ik hoop dat we in de toekomst nog veel zullen samenwerken.
Dr. L.P.W.J. van den Heuvel. Beste Bert, ik vond het een voorrecht jou in het
“promotie-team” te hebben. De moleculaire biologie is voor een perifeer neuroloog
allesbehalve gesneden koek. Je hebt me wegwijs gemaakt en steeds fantastisch
gesteund.
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Prof.dr. M. Lammens. Beste Martin, jij verstaat als geen ander de kunst om op een
bescheiden, ingetogen manier zeer scherpzinnige analyses naar voren te brengen. Ik heb
je inbreng zeer gewaardeerd.
Dr. M.W.I.M. Horstink. Beste Martin, jij hebt aan de basis gestaan van het
proefschrift. “Onze” patiënt met de rusttremor bleek AT te hebben. Oprechte dank voor
je hulp aan het eerste, achteraf zo belangrijke, AT artikel. 
Dr. M.J. van Belzen. Beste Martine, mede dank zij jou is het proefschrift goed van de
grond gekomen. Dank voor je inzet bij de genetische studies.
Dr. A. Broeks. Beste Annegien, jouw rol bij de genetische studies is cruciaal geweest.
Zonder jouw hulp was het nooit een “dichtgetimmerd geheel” geworden. Veel dank
daarvoor.
Dr. A.M.R. Taylor and dr. P. Concannon. Dear collaegues, it was an honour for me
that you participated in the project. Thank you very much for the molecular genetic
studies.
Dr. K.H. Chrzanovska and dr. E. Seemanová. Dear collaegues, to have met you in
Praha, has been a pleasure and honour to me. Thank you very much for your important
contributions to the NBS studies.  
Dr. P. Dellemijn, A. Valkenburg en F.H.M. Kornips. Beste Paul, beste Anton en beste
Bert, dank voor jullie adviezen en ondersteuning de afgelopen jaren. Ik hoop nog lange
tijd met jullie in Máxima Medisch Centrum samen te blijven werken.
De assistenten neurologie, in het bijzonder Nanneke van Verseveld en Elisabeth
Visser. Dank voor jullie inzet en luisterend oor; Elisabeth dank voor je correcties van
het Engels.
Secretariaat neurologie. Hetty, Rian, Marjon, Gertie,  Lisanne, Janneke, Anja en
Marita. Dank voor jullie belangrijke logistieke en administratieve ondersteuning. Ik
heb dat zeer gewaardeerd.
Henk Dinnissen. Beste Henk, wat zou Máxima Medisch Centrum zijn zonder jou? Jij
bent een authoriteit op het gebied van de visuele presentatie en vormgeving. Zeer veel
dank voor het feit dat je de lay-out van het proefschrift hebt willen verzorgen. 
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Pa en ma, jullie hebben mij doorzettingsvermogen geleerd. Dat is de basis geweest
voor het welslagen van dit werk. Het Zeeuwse adagium “luctor et emergo” (ik worstel
en kom boven) is zeker van toepassing geweest. Veel dank.
Last but not least. Lieve Jacqueline, Marjolein en Stephan, jullie hebben de afgelopen
jaren tot vervelends toe steeds moeten horen: “Pas na mijn promotie dan krijg ik tijd,
zeeën van tijd voor talrijke leuke dingen die we samen gaan doen, zoals tennissen,
voetballen, zwemmen, fietsen, hockyen, muziekmaken, schaken en nog veel meer”.
Bedankt dat jullie het geduld hebben kunnen opbrengen. Het is bijna niet te geloven,
maar het is eindelijk zover, het gaat nu echt gebeuren…
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Curriculum vitae 
De auteur van dit proefschrift werd op 13 december 1960 geboren te Hulst. Hij groeide
op in Ossenisse, een klein plaatsje in Oost Zeeuws-Vlaanderen. In 1979 behaalde hij het
diploma Atheneum B aan het R.K. Jansenius S.G. te Hulst. Vervolgens studeerde hij
geneeskunde aan de Katholieke Universiteit Nijmegen, alwaar in 1986 het artsexamen
werd behaald. 
Daarna is hij ruim vier en een half jaar werkzaam geweest in het Gemeenteziekenhuis
te Arnhem (thans Rijnstate ziekenhuis), aanvankelijk als AGNIO neurologie, later als
AGIO neurologie (opleider: dr. G. Schouwink (†), B-opleiding met academisch
ziekenhuis St. Radboud). Tussendoor werd aldaar nog een jaar inwendige geneeskunde
gedaan (opleider: dr. J. Werre). 
De specialisatie neurologie werd vanaf 1991 verder vervolgd in het Academisch
Ziekenhuis Nijmegen St Radboud (thans Universitair Medisch Centrum St Radboud) 
en in 1994 voltooid (opleiders: Prof.dr. B.P.M. Schulte (†), dr. H.C. Schoonderwaldt 
en Prof.dr. G.W.A.M. Padberg). De aantekening klinische neurofysiologie werd in
hetzelfde ziekenhuis behaald in 1996 (opleiders: Prof.dr. S.L.H. Notermans en 
drs. H.M. Vingerhoets).
Sedert 1 januari 1997 is hij full time werkzaam in Máxima Medisch Centrum te
Veldhoven (voorheen het Sint Joseph Ziekenhuis), alwaar hij deel uitmaakt van de
maatschap neurologie. De auteur is gehuwd en heeft twee kinderen.
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